Variable fit fluid collection devices, systems, and methods

Information

  • Patent Grant
  • 11865030
  • Patent Number
    11,865,030
  • Date Filed
    Thursday, May 12, 2022
    2 years ago
  • Date Issued
    Tuesday, January 9, 2024
    4 months ago
Abstract
Examples relate to fluid collection devices, systems, and methods of collecting fluid from wearers. The fluid collection devices include a retention means for maintaining the position of the fluid collection device with respect to the wearer.
Description
BACKGROUND

An individual may have limited or impaired mobility such that utilizing a restroom is challenging or impossible. For example, the individual may have a condition, had a surgery, or a have disability that impairs mobility. Additionally, bodily fluid collection from the individual may be needed for monitoring purposes or clinical testing.


Bedpans and other common urine collection devices suffer from various drawbacks, such as difficulty of use, embarrassing visibility of urine in the device, and some devices cannot be worn at all times, thereby making spills and leakage a risk. Thus, users and manufacturers of patient care beds continue to seek new and improved devices, systems, and methods to prevent patient's clothing and beds from becoming soiled.


SUMMARY

Embodiments disclosed herein are related to fluid collection devices, systems, and methods of collecting fluid from wearers, where the fluid collection devices include a retention means for maintaining the position of the fluid collection device with respect to the wearer


In an embodiment, a fluid collection device is disclosed. The fluid collection device includes a fluid impermeable barrier defining an interior chamber therein and an opening through which the interior chamber is accessible. The fluid collection device includes a porous material disposed in the interior chamber. The fluid collection device includes a conduit fluidly connected to the interior chamber. The fluid collection device includes a retention means for retaining positioning of the fluid collection device with respect to the wearer.


In an embodiment, a fluid collection system is disclosed. The fluid collection system includes a fluid storage container configured to hold a fluid. The fluid collection system includes a fluid collection device having a fluid impermeable barrier defining an interior chamber therein and an opening through which the interior chamber is accessible, a porous material disposed in the interior chamber, a conduit fluidly connected to the interior chamber, a retention means for retaining positioning of the fluid collection device with respect to the wearer. The fluid collection system includes at least one vacuum source fluidly coupled to the fluid storage container, the at least one vacuum source configured to draw fluid into the at least one fluid storage container from the fluid collection device via the conduit.


In an embodiment, a method for collecting fluid is disclosed. The method includes positioning a fluid collection device on a wearer, the fluid collection device including a fluid impermeable barrier defining an interior chamber therein and an opening through which the interior chamber is accessible, a porous material disposed in the interior chamber, a conduit fluidly connected to the interior chamber, and a retention means for retaining positioning of the fluid collection device with respect to the wearer. The method includes engaging the retention means of the fluid collection device. The method includes receiving fluid into the fluid collection device.


Features from any of the disclosed embodiments may be used in combination with one another, without limitation. In addition, other features and advantages of the present disclosure will become apparent to those of ordinary skill in the art through consideration of the following detailed description and the accompanying drawings.





BRIEF DESCRIPTION OF THE DRAWINGS

The drawings illustrate several embodiments of the present disclosure, wherein identical reference numerals refer to identical or similar elements or features in different views or embodiments shown in the drawings.



FIG. 1 is a front view of a fluid collection device for females, according to an embodiment.



FIG. 2 is a cross-sectional view of the fluid collection device of FIG. 1.



FIGS. 3 and 4 are cross-sectional views of a deformable conduit, according to an embodiment.



FIG. 5 is an isometric view of a portion of a deformable conduit, according to an embodiment.



FIG. 6 is a close-up partial cut-away view of the deformable conduit of FIG. 5.



FIG. 7 is a side view of a fluid collection device changing from a compressed to an uncompressed state, according to an embodiment.



FIGS. 8 and 9 are isometric views of a fluid collection device, according to an embodiment.



FIGS. 10A and 10B are illustrations of the fluid collection device of FIGS. 8 and 9 in cross-section during positioning.



FIGS. 11 and 12 are top views of a fluid collection device having a mucoadhesive applied thereto, according to an embodiment.



FIG. 13 is a block diagram of a system for collecting fluid, according to an embodiment.



FIG. 14 is a flow diagram of a method for collecting fluid, according to an embodiment.





DETAILED DESCRIPTION

Embodiments disclosed herein are related to devices, systems, and methods for collecting fluid with fluid collection devices having means for retaining position with respect to a wearer. The devices, systems, and methods of disclosed herein include fluid collection devices having a fluid impermeable barrier defining an interior chamber therein, a porous material disposed at least partially within the interior chamber, and a conduit extending into the interior chamber to remove fluids collected within the interior chamber by the porous material. The retention means allow the porous material of the fluid collection device to remain positioned on or over the urethra of the wearer during use. The various retention means provide one or more of conformational rigidity, conformability to wearer anatomy, friction fit with wearer anatomy, or mucoadhesion with wearer anatomy.


In a first example, a fluid collection device includes a selectively deformable spine in or around the conduit to maintain a shape of the fluid collection device. FIG. 1 is a front view of a fluid collection device 100 for females, according to an embodiment. The fluid collection device 100 includes a fluid impermeable barrier 102 defining an interior chamber therein and an opening 106. The fluid collection device 100 includes porous material 115 disposed in the interior chamber and exposed through the opening 106. The fluid collection device 100 includes a conduit 108 (e.g., drainage tube) disposed in the interior chamber and entering from the first end region 125 and extending to the second end region 127. The fluid collection device 100 is sized, shaped, and constructed to collect urine or other fluids from the urethra of the wearer.


The fluid impermeable barrier 102 may be formed of any suitable fluid impermeable material(s), such as a fluid impermeable polymer (e.g., silicone, polypropylene, polyethylene, polyethylene terephthalate, thermoplastic elastomer(s), a polycarbonate, etc.), a metal film, natural rubber, another suitable material, or combinations thereof. As such, the fluid impermeable barrier 102 substantially prevents the fluid(s) from passing therethrough. The fluid impermeable barrier 102 at least partially defines the interior chamber (e.g., interior region) therein and the opening 106. For example, the inner surface(s) of the fluid impermeable barrier 102 at least partially defines the interior chamber within the fluid collection device 100. The fluid impermeable barrier 102 at least temporarily retains the fluid(s) in the interior chamber. One or more portions of at least the outer surface of the fluid impermeable barrier 102 may be formed from a soft and/or smooth material, thereby reducing chaffing.


The fluid impermeable barrier 102 may be tubular (ignoring the opening), such as substantially cylindrical (as shown), oblong, prismatic, flattened tube, or any other extruded shape (e.g., a tube having multiple flanges). The fluid impermeable barrier 102 may be sized to fit between the legs of a wearer. During use, the outer surface of the fluid impermeable barrier 102 may at least partially contact the wearer.


The opening 106 provides an ingress route for fluids to enter the interior chamber. The opening 106 may be defined by the fluid impermeable barrier 102, such as by an inner edge of the fluid impermeable barrier 102. For example, the opening 106 is formed in and extends through the fluid impermeable barrier 102, from the outer surface to the inner surface, thereby enabling fluid(s) to enter the interior chamber from outside of the fluid collection device 100. The opening 106 is located and shaped to be positioned adjacent to a wearer's urethra while the device is in use. At least a portion of porous material(s) 115 disposed in the interior may be exposed through the opening 106 to allow fluids to move inwardly into the interior chamber, such as via one or more of permeation, suction, or wicking.


The fluid collection device 100 may be positioned proximate to the urethra and urine may enter the interior chamber via the opening 106. When in use, the opening 106 may be elongated, extending from a first location below the urethra to a second location above the urethra (e.g., at or near the top of the vaginal opening or the pubic region). The opening 106 may exhibit an elongated shape because the space between the legs of a wearer is relatively narrow when the legs of the wearer are closed, thereby only permitting the flow of the fluid(s) along a path that corresponds to the elongated shape of the opening 106 (e.g., longitudinally extending opening). The opening 106 in the fluid impermeable barrier 102 may exhibit a length that is measured along the longitudinal axis of the fluid collection device 100 that may be at least about 10% of the length of the fluid collection device 100, such as about 10% to about 95% of the length of the fluid collection device 100. The opening 106 in the fluid impermeable barrier 102 may exhibit a width that is measured transverse to the longitudinal axis of the fluid collection device 100 and may be at least about 10% of the circumference of the fluid collection device 100, such as about 10% to about 75% of the circumference of the fluid collection device. The opening 406 may be longitudinally oriented (e.g., having a major axis parallel to the longitudinal axis of the device 100.


The fluid collection device 100 includes the porous material 115 disposed in the interior chamber. FIG. 2 is a cross-sectional view of the fluid collection device 100. The fluid collection device 100 includes the porous material 115 including a fluid permeable support 120 within a fluid permeable membrane 118 and a conduit 108 extending through the porous material 115. The porous material 115 includes a material that allows fluids to flow therethrough. For example, the porous material 115 may be configured to wick any fluid away from the opening 106, thereby preventing the fluid from escaping the interior chamber. The permeable properties of the porous material referred to herein may be wicking, capillary action, diffusion, or other similar properties or processes, and are referred to herein as “permeable” and/or “wicking.” Such “wicking” may not include absorption of fluid into the porous material. Put another way, substantially no absorption of fluid into the porous material may take place after the material is exposed to the fluid and removed from the fluid for a time. While no absorption is desired, the term “substantially no absorption” may allow for nominal amounts of absorption of fluid into the porous material (e.g., absorbency), such as less than about 10 wt % of the dry weight of the porous material, less than about 5 wt %, less than about 3 wt %, less than about 1 wt %, or less than about 0.5 wt % of the dry weight of the porous material 115. The porous material 115 may also wick the fluid generally towards a central region or reservoir of the interior chamber.


The porous material 115 may include more than one material arranged concentrically within the interior chamber, such as gauze disposed over spun plastic fibers (e.g., spun nylon fibers). For example, the porous material 115 may include one or more of a fluid permeable membrane 118 or a fluid permeable support 120 disposed thereunder. The fluid permeable membrane 118 may include any porous material or a material that may wick the fluid. For example, the fluid permeable membrane 118 may include fabric, such as a gauze (e.g., a silk, linen, or cotton gauze), another soft fabric, or another smooth fabric. The fluid permeable membrane 118 may include spun plastic fibers (e.g., spun nylon fibers), such as a spun plastic mat or bed. Forming the fluid permeable membrane 118 from gauze, soft fabric, and/or smooth fabric may reduce chafing caused by the fluid collection device 100 against a wearer.


The fluid collection device 100 may include the fluid permeable membrane 118 disposed in the interior chamber. For example, the fluid permeable membrane 118 may cover at least a portion (e.g., all) of the opening 106.


The porous material 115 of the fluid collection device 100 may include the fluid permeable support 120 disposed in the interior chamber below the fluid permeable membrane 118. The fluid permeable support 120 may be composed to support the fluid permeable membrane 118 since the fluid permeable membrane 118 may be formed from a foldable, flimsy, or otherwise easily deformable material. For example, the fluid permeable support 120 may be positioned such that the fluid permeable membrane 118 is disposed between the fluid permeable support 120 and the fluid impermeable barrier 102. As such, the fluid permeable support 120 may support and maintain the position of the fluid permeable membrane 118 thereon. The fluid permeable support 120 may include any porous, fluid permeable material, such as a material that may wick the fluid. For example, the fluid permeable support 120 may include any of the fluid permeable membrane materials disclosed herein. The fluid permeable support 120 may be formed from any fluid porous material that is less deformable than the fluid permeable membrane 118, such as any of the materials disclosed herein for the fluid permeable membrane 118, in a more dense or rigid form. In some examples, the fluid permeable support 120 may include a porous polymer (e.g., nylon, polyester, polyurethane, polyethylene, polypropylene, etc.) structure, an open cell foam, or spun plastic fibers (e.g., nylon fibers). In some examples, the fluid permeable membrane 118 may include gauze and the fluid permeable support 120 may include spun nylon fibers. In some examples, the fluid permeable support 120 may be formed from fabric, felt, gauze, or combinations thereof. In some examples, the fluid permeable support 120 may be formed from a natural material, such as cotton, wool, silk, or combinations thereof. In such examples, the material may have a coating to prevent or limit absorption of fluid into the material, such as a water repellent coating. In some examples, the fluid permeable support 120 may be omitted from the fluid collection device 100. In some examples, the fluid permeable membrane 118 may be optional. For example, the porous material 115 may include only the fluid permeable support 120.


The fluid permeable support may have a greater permeability or a greater ability to wick fluids than the fluid permeable membrane 118, such as to move the fluid inwardly from the outer surface of the fluid collection device 100 through the permeable membrane 118 and into the fluid permeable support. In some examples, the permeability or the wicking ability of the fluid permeable support and the fluid permeable membrane 118 may be substantially the same.


The fluid impermeable barrier 102, the porous material 115 may be sized and shaped to have the conduit 108 at least partially disposed in the interior chamber. For example, at least one of the fluid permeable membrane 118 and the fluid permeable support 120 may be configured to form a space that accommodates the conduit 108. The fluid impermeable barrier 102 may define an aperture sized to receive the conduit 108 therethrough. The aperture may be sized and shaped to form an at least substantially fluid tight seal against the conduit 108 thereby substantially preventing the fluid(s) from escaping the interior chamber. The fluid collected in the fluid collection device 100 may be removed from the interior chamber via the conduit 108.


The porous material 115 may extend across at least a portion (e.g., all) of the opening 106. At least a portion of the porous material 115 may be exposed to an environment outside of the interior chamber through the opening 106. The fluid permeable membrane 118 and the fluid permeable support 120 may at least substantially completely fill the portions of the interior chamber that are not occupied by the conduit 108. In another example, the fluid permeable membrane 118 and the fluid permeable support 120 may not substantially completely fill the portions of the interior chamber that are not occupied by the conduit 108. In such an example, the fluid collection device 100 includes reservoir 122 in the interior chamber. The reservoir 122 is defined between the fluid impermeable barrier 102 and the porous material 115 in the interior chamber. The reservoir 122 may be located in a portion of the fluid collection device 100 expected to be positioned in a gravimetrically low point of thereof when worn by a user. While depicted in the second end region 127, the reservoir 122 may be located in any portion of the interior chamber such as the first end region 125.


As shown in FIG. 1, the fluid collection device 100 includes conduit 108 (e.g., drainage tube) which extends in the interior chamber. The conduit 108 may include a flexible material such as polymer tubing (e.g., medical tubing) material. Such polymer tubing material may include a thermoplastic elastomer, polyvinyl chloride, ethylene vinyl acetate, polytetrafluoroethylene, etc., tubing. In some examples, the conduit 108 may include silicon or latex. In some examples, the conduit 108 may include one or more portions that are resilient, such as to by having one or more of a diameter or wall thickness that allows the conduit 108 to be flexible. In some examples, the conduit 108 may be frosted or opaque (e.g., black) to obscure visibility of the fluid(s) therein.


The conduit 108 includes an inlet at a first end region and an outlet at a second end region positioned downstream from the inlet. The conduit 108 may extend into the interior chamber to any point therein. For example, the conduit 108 may be inserted into the interior chamber at the first end region 125 of the fluid collection device 100 and extend therethrough to the second end region 127. The conduit 108 may extend into the fluid impermeable barrier 102 from the first end region 125 through to the second end region 127 to a point proximate to the reservoir 122 such that the inlet is in fluid communication with the reservoir 122. In some examples (not shown), the conduit 108 may enter the interior chamber in the second end region 127 and the inlet of the conduit 108 may be disposed in the second end region 127 (e.g., in the reservoir 122 or flush with fluid impermeable barrier 102). The fluid collected in the reservoir 122 may be removed from the interior chamber via the conduit 108. In some examples, the inlet may be disposed at the end of the porous material 115 in the second end region 127, such as flush with the end of the fluid permeable support 120. In some examples, the inlet of the conduit 108 may be disposed within the fluid permeable support 120 such between first end region 125 and the second end region 127.


Other examples of fluid impermeable barriers, porous materials, chambers, conduits and their shapes and configurations are disclosed in U.S. patent application Ser. No. 15/612,325 filed on Jun. 2, 2017; U.S. patent application Ser. No. 15/260,103 filed on Sep. 8, 2016; and U.S. Pat. No. 10,226,376 filed on Jun. 1, 2017, the disclosure of each of which is incorporated herein, in its entirety, by this reference.


The conduit 108 provides a selectively deformable spine within the fluid collection device 100. Upon manual manipulation, the conduit 108 may hold the fluid collection device 100 in a specific shape, such as the illustrated curved shape. For example, the fluid collection device 100 is able to deform to the curvature of the body between the glutes and the labia by manipulating the conduit 108. The reduction in tension along the spine of the fluid collection device 100 provided by the conduit 108 reduces the likelihood of detachment or misalignment of the fluid collection device 100 from the urethra (e.g., on top of the labia).


Disclosed below are examples for the conduit 108 to provide a selectively deformable spine in the fluid collection device 100. FIGS. 3 and 4 are cross-sectional views of a deformable conduit 108a, according to an embodiment. As shown in FIG. 3, the deformable conduit 108a includes tubing 109 disposed over flexible gooseneck tubing 110. The gooseneck tubing 110 may be a modular hose that is capable of manipulation responsive to external forces and rigid retention of a selected configuration after manipulation. For example, the gooseneck tubing 110 may include a ball and socket construction such as a Loc-Line® type modular hose or the like. The size of the balls and sockets of the gooseneck tubing 110 provide a selected fit therebetween (e.g., slip fit, interference fit, etc.) to provide a selected amount of resistance to deformation. Accordingly, the deformable conduit 108a may be selectively shaped (e.g., deformed) and retain the selected shape or conformation. In some examples, the gooseneck tubing 110 may be constructed of polymer balls and sockets.


As shown in FIG. 4, the gooseneck tubing 110 includes an interior passageway therein for enabling fluid to move therethrough. The interior passageway is formed by the interior walls of the balls and sockets of the gooseneck tubing, which have a selected bore size therein. The fluids (e.g., urine) collected in the fluid collection device having the deformable conduit 108a flow though the interior passageway of the deformable conduit 108a as the fluid drains therefrom.


The gooseneck tubing 110 may or may not be fluid tight. Accordingly, the tubing 109 therearound may help retain fluids within the deformable conduit 108a. The tubing 109 may be relatively soft and flexible compared to conventional drainage tubing. The tubing 109 provides a cushion between the wearer and the gooseneck tubing 110. The tubing 109 may be constructed of a polymer such as a thermoplastic elastomer, polyvinyl chloride, ethylene vinyl acetate, polytetrafluoroethylene, etc., or combinations of any of the foregoing. In some examples, the tubing 109 may include silicone or latex. The tubing 109 may have a wall thickness of at least about 1 mm, such as about 1 mm to about 5 mm, or less than 10 mm. The deformable conduit 108a may include tubing 109 having a thickness that prevents wearers from feeling the gooseneck tubing 110 therebelow.


The diameter or greatest dimension of the gooseneck tubing 110 may be about 13 mm or less, such as about 5 mm to about 13 mm, about 5 mm to about 8 mm, about 8 mm to about 13 mm, or more than about 8 mm. In some examples, the diameter or greatest dimension of the deformable conduit 108a (including the outer dimensions of the tubing 109 disposed over the gooseneck tubing 110) may be about 13 mm or less, such as about 5 mm to about 13 mm, about 5 mm to about 8 mm, about 8 mm to about 13 mm, or more than about 8 mm. Fluid collection devices incorporating the deformable conduit 108a may include porous material having a thickness that prevents wearers from feeling the gooseneck tubing 110 of the deformable conduit 108a therebelow.


The gooseneck tubing 110 may extend only along a portion of the deformable conduit 108a, such as the portion inside of the interior chamber or from inside of the interior chamber to a distance outside of the first end region 125 of the fluid collection device containing the same, such as at least 1 cm past the aperture through which the conduit 108a is inserted into the fluid collection device. The deformable conduit 108a may be used in any of the examples of fluid collection devices disclosed herein.


Different deformable conduits may be utilized in fluid collection devices. FIG. 5 is an isometric view of a portion of the deformable conduit 108b, according to an embodiment. FIG. 6 is a close-up partial cut-away view of the deformable conduit 108b of FIG. 5. The deformable conduit 108b may include a plurality of fibers 111 sandwiched between tubing 109 and an outer tube 112. The plurality of fibers 111 may include polymer fibers or wires. The plurality of fibers may include wires including one or more of polycarbonate, polyethylene, polyvinylchloride, polypropylene, polyolefin, fluorinated polymers (polytetrafluoroethylene), polyamide, or the like. The width of the fibers or wires may be 0.1 mm or more, such as 0.1 mm to 3 mm, 0.1 mm to 1 mm, 1 mm to 3 mm, less than 3 mm, or less than 1 mm. As the deformable conduit 108b is bent, the polymer fibers move past each other and the friction therebetween holds them in the new position to prevent spring back. The plurality of fibers may be packed between the outer tube 112 and the tubing 109 with a selected spacing to provide a selected fit therebetween, such as a slip fit, a tension fit, an interference fit, or the like. The tightness of the packing within the plurality of fibers 111 can provide fine tuning of the stiffness of the deformable conduit 108b. Accordingly, the deformable conduit 108b may retain a selected shape according to manual manipulation and may resist forces of a selected magnitude to change the shape.


The tubing 109 may be as disclosed herein with respect to the deformable conduit 108a. The outer tube 112 may be similar or identical to the conduit 108 or the tubing 109, in one or more aspects. For example, the outer tubing 112 may including a polymer conduit, such as thermoplastic elastomer, polyvinyl chloride, ethylene vinyl acetate, polytetrafluoroethylene, silicone, latex, or combinations thereof.


The plurality of fibers 111, tubing 109, and outer tube may extend only along a portion of the deformable conduit 108b, such as the portion inside of the interior chamber or from inside of the interior chamber to a distance outside of the first end region of the fluid collection device containing the same, such as at least 1 cm past the aperture through which the conduit 108b is inserted into the fluid collection device. The deformable conduit 108b may be used in any of the examples of fluid collection devices disclosed herein.


The deformable conduits 108a and 108b may be sized and shaped to conform the fluid collection devices carrying the same to the anatomy of a wearer along the sagittal plane of the wearer, such as in the pelvic region. Such examples provide fluid collection devices that can be manipulated to a selected shape and may resist changing from the selected shape, such as from movement of the wearer.


In some examples, the fluid collection device may be at least partially held in place by a resiliently compressible design. FIG. 7 is a side view of fluid collection device 200 changing from a compressed to an uncompressed state. The fluid collection device 200 includes the fluid impermeable barrier 202, the porous material 215, and the conduit 108 extending therethrough. The fluid collection device 200 is resiliently compressible and may at least partially hold a shape responsive to pressure applied thereto.


The porous material 215 includes a soft, resilient foam, such as a viscoelastic foam (e.g., memory foam or low-resilience polyurethane). Accordingly, the porous material 215 is compressible. The resilient foam of the porous material 215 is an open cell foam to allow fluids to pass therethrough. The porous material 215 may include one or more of the fluid permeable membrane or the fluid permeable support. The resilient foam of the porous material 215 may be used alone as a fluid permeable membrane or the fluid permeable support. In the latter case, a fluid permeable membrane, such as any of those disclosed herein (e.g., gauze) may be disposed over the resilient foam.


The fluid impermeable barrier 202 is a soft malleable material capable of being deformed and springing back to an original shape, either alone or as forced by the resilient foam of the porous material 215. The fluid impermeable barrier 202 may be similar or identical to the fluid impermeable barrier 102 in one or more aspects. The fluid impermeable barrier 202 may include silicone, rubber, or a polymer as disclosed herein. The fluid impermeable barrier 202 may be thin layer directly attached to the porous material 215, such as a coating thereon. For example, the fluid impermeable barrier may be a waterproof polyurethane laminate fabric or the like, which may be welded directly to the foam or wrapped therearound.


The conduit 108 may be made of a relatively malleable (compared to conventional medical drainage tubing), fluid-tight material. For example, the conduit 108 may be made of one or more of polyethylene, polyvinyl chloride, latex, silicone, or a mixture thereof. Higher amounts of silicone provide a softer, more malleable conduit 108. The conduit 108 is malleable responsive to pressure such that the fluid collection device 200 is not shaped by the stiffness of the conduit 108.


In use, the fluid collection device 200 is compressed and inserted or pressed against the anatomy of the wearer. As the fluid collection device 200 returns to an expanded shape, the fluid collection device 200 at least partially conforms to the anatomy of the wearer. Accordingly, the fluid collection device 200 provides an improved anatomical fit to increase comfort, maintain position on the wearer, and decrease leakage over less conformable materials and devices. The resiliently compressible components (e.g., the resilient foam of the porous material 215) provides a means of retaining the fluid collection device 200 in position on the wearer. The deformable conduits 108a and 108b may be used with the fluid collection device 200.


In some examples, the shape of the fluid collection device is generally preformed to the shape of labia and can be manipulated from a closed state to an open state by compression of a portion thereof. FIGS. 8 and 9 are isometric views of fluid collection device 300, according to an embodiment. FIGS. 10A and 10B are illustrations of the fluid collection device 300 in cross-section during positioning. The fluid collection device 300 includes fluid impermeable barrier 302 having labial flanges 303 extending outwardly from a longitudinal axis thereof, porous material 315, the conduit 108, and lobes 356 extending longitudinally along the back of the fluid collection device 300.


The fluid impermeable barrier 302 includes an outer surface and an inner surface that defines an interior chamber therein. The fluid impermeable barrier 302 includes an opening 306. The fluid impermeable barrier 302 at least partially defines the labial flanges 303 and the lobes 356. The porous material 315 is at least partially disposed in the interior chamber and protrudes therefrom through the opening 306. The conduit 108 extends into the interior chamber via fluid impermeable barrier, such as into the porous material (e.g., to a reservoir in the interior chamber). The porous material 315 may be similar or identical to any of the porous material(s) disclosed herein, such as having a fluid permeable membrane and a fluid permeable support. The fluid impermeable barrier 302 is formed of a fluid impermeable material such as any of the fluid impermeable materials disclosed herein.


The labial flanges 303 are shaped with longitudinally extending valleys sized to at least partially accommodate labia majora therein. The labial flanges 303 may be at least partially rigid. The fluid impermeable barrier 302 converges to an apex 316 along the longitudinal axis in the first end region 325. The porous material 315 also includes an apex 316 along the longitudinal axis. Accordingly, the apex 316 may be positioned between the labia majora and the valleys accommodate the labia majora during use. The outer surfaces of the labial flanges 303 (e.g., on the wearer facing surface) may be textured or tacky for frictional engagement with the labia of the wearer. The longitudinal shape of the fluid collection device or portions thereof may be at least slightly arcuate to complement the shape of wearer anatomy.


On the back of the fluid collection device 300, the fluid impermeable barrier 302 defines the lobes 356. The lobes 356 have a valley therebetween. The lobes may longitudinally extend along at least a portion of the back side of the fluid collection device 300. The lobes 356 may be pinched inwardly, as shown in FIGS. 10A and 10B, to open the labial flanges 303 and expose the apex 316. For example, the lateral ends of the labial flanges 303 rotate away from the apex 316 when the lobes 356 are pinched due to tension applied across the fluid impermeable barrier 302. The apex 316 may be inserted between the labia majora 350. Upon release, the lateral ends of the labial flanges 303 rotate back toward the apex 316 to engage the outer surface of the labia majora 350 with the valleys formed between the labial flanges 303 and the apex 316 at least partially containing the labia majora therein. Accordingly, the apex 316 of the porous material 315 may be positioned closer to the urethra of the wearer than cylindrical devices. The labial flanges 303 may hold onto the labia majora, by inward pressure or pinching after the inward pressure on the lobes 356 is released. Accordingly, an additional means of retention is provided by the shape of the fluid collection device 300.


In some examples, a fluid collection device may use a mucoadhesive to increase engagement with the wearer. FIGS. 11 and 12 are top views of a fluid collection device 400 having a mucoadhesive applied thereto, according to an embodiment. The fluid collection device 400 includes the fluid impermeable barrier 102 defining the outer surface and the inner surface which defines the interior chamber of the fluid collection device 400. The fluid collection device 400 includes the porous material 115. The porous material 115 is exposed through the opening 106 in the fluid impermeable barrier 102. The fluid collection device 400 includes the conduit 108 extending into the fluid impermeable barrier 102 and porous material 115 from the first end region to the second end region of the fluid collection device 400. The fluid collection device includes a mucoadhesive applied to at least a portion of the fluid impermeable barrier 102 in the regions 419.


The mucoadhesive in the region 419 adds a tackifier to the fluid impermeable barrier 102 which provides shear resistance with a nearly no impact on peel strength. The mucoadhesive may include a gum, a gel, a polymer, a tape, or combinations thereof. For example, the mucoadhesive gum may include a Tmarind/Xanthum gum or the like. The mucoadhesive in gel form may include a Gantrez/Sodium alginate gel or the like. In some examples, the mucoadhesive includes a tape having surface modifiers thereon, a low tack adhesive with a tackifying additive integrated to the fluid impermeable barrier. Other gums, gels, or polymers may be used. The mucoadhesive may be disposed on one or more portions of the fluid collection device 400, such as on the fluid impermeable barrier 102 in region 419 as shown in FIG. 11 or on the porous material 115 near the top of the opening in region 419 as shown in FIG. 12.


As shown in FIG. 11, the region 419 may be along the sides of the opening through which the porous material 115 is exposed. In such examples, the mucoadhesive may provide increased engagement with the inner legs (thighs) or labia of the wearer.


As shown in FIG. 12, the region 419 may be at the top of the opening through which the porous material 115 is exposed. In such examples, the mucoadhesive may be disposed on the fluid impermeable barrier 102 and/or porous material 115 at the top of the opening in region 419. In such examples, the mucoadhesive provides increased engagement with the pubic region of the wearer, thereby keeping the opening (and porous material 115 therein) over the urethra of the wearer.


The mucoadhesive included on the fluid collection device 400 provides and additional retention means to maintain the positioning of the fluid collection device 400 with respect to the wearer. By limiting the area that the mucoadhesive is disposed on, the wearer, the wearer's clothing, and bedding may be prevented from contamination by the mucoadhesive. Accordingly, the mucoadhesive retains the position of the fluid collection device on the wearer without introducing large amounts of adhesive onto the wearer.


During use, the fluid collection device(s) disclosed herein may be positioned such that the opening of the fluid collection device through which the porous material is exposed is disposed on or over the urethra of the wearer. The fluid collection device may receive bodily fluids (e.g., urine) from the urethra into the internal chamber. At least some of the bodily fluids may be removed from the urethra via the porous material (e.g., via wicking, absorptions, adsorption, etc.). The bodily fluids may flow towards the open end of the conduit in the reservoir (e.g., in the gravimetrically low point of the device) through the porous material in the interior chamber. The bodily fluids may be removed from the fluid collection device via the conduit. Suction force may be introduced into the interior chamber via the conduit responsive to suction (e.g., vacuum) force applied to the conduit by a vacuum source. The bodily fluids removed from the fluid collection device may be stored in the fluid storage container operably coupled to the vacuum source.


The fluid collection devices disclosed herein may be part of a fluid collection system. FIG. 13 is a block diagram of a system 500 for collecting fluid, according to an embodiment. The system 500 includes a fluid collection device 501 operably coupled to one or more of a fluid storage container 519 or a vacuum source 529, such as via the conduit(s) 108. The conduit 108 may fluidly connect an interior chamber of the fluid collection device 501 with the fluid storage container 519 or the vacuum source 529 (via the fluid storage container 519). Accordingly, fluids may be removed from the interior chamber via the conduit 108 via one or more of gravity feed or vacuum suction.


The fluid collection device 501 may be similar or identical to any of the fluid collection devices disclosed herein. For example, the fluid collection device 501 may include a fluid impermeable barrier, a fluid permeable body, and any of the retention means disclosed herein. The fluid collection device 501 may include the conduit 108 including an inlet and an outlet as disclosed herein. The outlet may be fluidly coupled to the fluid storage container 519 and the inlet may be positioned in the fluid collection device 501.


The conduit 108 is coupled to and at least partially extends between one or more of the fluid storage container 519 and the vacuum source 529. Accordingly, the vacuum source 529 may be fluidly connected to the fluid storage container 519 via the conduit 108. In an example, the conduit 108 is directly connected to the vacuum source 529. In some examples, the conduit 108 may be indirectly connected to at least one of the fluid storage container 519 and the vacuum source 529. In some examples, the conduit 108 may be secured to a wearer's skin with a catheter securement device, such as a STATLOCK® catheter securement device available from C. R. Bard, Inc., including but not limited to those disclosed in U.S. Pat. Nos. 6,117,163; 6,123,398; and 8,211,063, the disclosures of which are all incorporated herein by reference in their entirety.


Fluid (e.g., urine or other bodily fluids) collected in the fluid collection device 501 may be removed from the fluid collection device 501 via the conduit(s) 108. Vacuum or suction force may be applied to remove fluid from the fluid collection device via the conduit either directly or indirectly. The vacuum force may be applied indirectly via the fluid storage container 519. For example, the second open end of the conduit 108 may be disposed within the fluid storage container 519 and an additional conduit 108 may extend from the fluid storage container 519 to the vacuum source 529. Accordingly, the vacuum source 529 may indirectly apply vacuum or suction force into the fluid collection device 501 (e.g., chamber therein) via the fluid storage container 519 and conduit(s) 108. As the fluid is drained from the interior chamber of the fluid collection device 501, the fluid may travel through the first section of conduit 108 to the fluid storage container 519 where it may be retained.


The fluid storage container 519 is constructed to store fluids therein. The fluid storage container may include a bag (e.g., drainage bag), a rigid bottle or cup (e.g., collection jar), or any other enclosed container for storing bodily fluids. The fluid storage container(s) may be fluidly connected to the vacuum source(s) 529, such as via a portion of conduit 108. The vacuum source(s) 529 provides a vacuum for pulling fluids from one or more of the fluid collection device 501 into the fluid storage container 519 via the conduit 108. The fluid collected in the fluid collection device 501 is moved through the conduit into the fluid storage container. By having a separate connection to the vacuum source 529 on the fluid storage container 519, the fluids removed from the fluid collection device 501 may be prevented from entering the vacuum source 529.


The vacuum source may include one or more of a manual vacuum pump, an electric vacuum pump, a diaphragm pump, a centrifugal pump, a displacement pump, a magnetically driven pump, a peristaltic pump, or any pump configured to produce a vacuum. The vacuum source may include a wall mounted suction line, such as found in a hospital room. In examples, the vacuum source may be powered by one or more of a power cord (e.g., connected to a power socket), one or more batteries, or even manual power (e.g., a hand operated vacuum pump). The vacuum source may include one or more of a switch, a button, a plug, a remote, or any other actuator suitable to activate the vacuum source. The vacuum source may be selectively operated by a user (e.g., medical personnel, the wearer, or a caretaker).


Any of the fluid collection devices and systems disclosed herein may be utilized to collect fluid, such as urine, from a wearer of the fluid collection device. FIG. 14 is a flow diagram of a method 600 for collecting fluid, according to an embodiment. The method 600 includes the act 610 of positioning a fluid collection devices on a wearer, the fluid collection device including a fluid impermeable barrier defining an interior chamber therein and an opening through which the interior chamber is accessible; a porous material disposed in the interior chamber; a conduit fluidly connected to the interior chamber; and a retention means for retaining positioning of the fluid collection device with respect to the wearer. The method 600 includes the act 620 of engaging the retention means. The method 600 includes the act 630 of receiving fluid in the fluid collection device. Any the acts 610, 620, or 630 of the method 600 may be performed in different orders, split into multiple acts, modified, supplemented, or combined. For example, the acts 610 and 620 may be combined into a single act. In some examples, one or more of the blocks 610-630 of the method 600 may be omitted or additional acts may be added.


Any of the fluid collection devices disclosed herein may be used in the method 600. For example, the act 610 may include positioning any of the fluid collection devices disclosed herein on a wearer in a position to collect urine therefrom. The fluid collection device includes a fluid impermeable barrier defining an interior chamber therein and an opening through which the interior chamber is accessible, a porous material disposed in the interior chamber, a conduit fluidly connected to the interior chamber, and a retention means for retaining positioning of the fluid collection device with respect to the wearer. The retention means of the fluid collection device may include one or more of any of the retention means disclosed herein.


The act 610 of positioning a fluid collection devices on a wearer may include positioning the opening of the fluid collection device over, near, or on the urethra of the wearer. Positioning the fluid collection device on a wearer may include positioning the opening on, around, or over the labia or vulva of the wearer. Positioning the fluid collection device on a wearer (e.g., positioning the opening adjacent to a urethra of a wearer) may include positioning the second end region of the fluid collection device against or near the perineal region of the wearer with the first end region against or near the pubic region of the wearer.


The act 620 of engaging the retention means may include engaging any of the retention means disclosed herein. The act 620 of engaging the retention means may include manipulating the retention means to engage with anatomical features of the wearer to retain the fluid collection device on the wearer. For example, engaging the retention means may include manipulating the retention means to cause at least a portion of the fluid collection device to complement the shape of the anatomy of the wearer, such as the shape in the sagittal plane from the perineal region to the pubic region of the wearer, the shape of the labia of the wearer, the space between the legs of the wearer, or the like.


In examples where the retention means includes a deformable conduit (FIGS. 2-6), engaging the retention means may include bending or shaping the deformable conduit to complement the shape of the anatomy of the wearer (such as the shape in the sagittal plane from the perineal region to the pubic region of the wearer). For example, where the deformable conduit includes gooseneck tubing having tubing disposed thereover, engaging the retention means may include manually manipulating the gooseneck tubing into a selected shape such as an arcuate shape to conform to the anatomy of the wearer along the sagittal plane from the pubic region to the perineal region of the wearer. In such examples, the opening of the fluid collection device is located over the urethra of the wearer and maintained there at least in part due to the shape of the fluid collection device that is maintained by the gooseneck tubing (which includes a fit and dimension between sections of the gooseneck tubing that allows the gooseneck tubing to maintain a shape unless a force of a selected magnitude is applied thereto). The tubing disposed over the gooseneck tubing also prevents a wearer from feeling the sections of gooseneck tubing, while also allowing urine or other fluids to be removed from the tubing, such as via vacuum.


Where the deformable conduit includes gooseneck tubing having tubing disposed thereover, engaging the retention means may include manually manipulating the gooseneck tubing into a selected shape such as an arcuate shape to conform to the shape of the wearer along the sagittal plane from the pubic region to the perineal region of the wearer. In such examples, the opening of the fluid collection device is located over the urethra of the wearer and maintained there at least in part due to the shape of the fluid collection device that is maintained by the gooseneck tubing (which includes a fit and dimension between sections of the gooseneck tubing that allows the gooseneck tubing to maintain a shape unless a force of a selected magnitude is applied thereto).


In examples, where the deformable conduit includes a plurality of fibers disposed between an inner tubing and an outer tube, engaging the retention means may include bending the deformable conduit to a selected shape. The deformable conduit with a plurality of fibers therein may be bent into a selected shape such as an arcuate shape to conform to the shape of the wearer along the sagittal plane from the pubic region to the perineal region of the wearer. In such examples, the opening of the fluid collection device is located over the urethra of the wearer and maintained there at least in part due to the shape of the fluid collection device that is maintained by the plurality of fibers. For example, as the deformable conduit is bent, the plurality of fibers may move past each other and the friction therebetween may hold them in the new position to prevent spring back.


In some examples, the retention means is at least partially defined by the porous material and the porous material includes a resilient foam that is compressible (FIG. 7). For example, the resilient foam may include a memory foam. In examples with resilient foam, engaging the retention means of the fluid collection device may include one or more of compressing, shaping, or molding the fluid collection device to a compressed state and allowing the fluid collection device to at least partially expand against the anatomy of the wearer. The fluid collection device may be biased into the anatomy of the wearer, such as with the opening over the urethra of the wearer and one or more portion of the fluid collection device may be allowed to expand to conform to the anatomy of the wearer. Accordingly, the fluid collection device may be held in place by conforming to the anatomy of the wearer, such as the labia, inner thighs, or other portions of the wearer. Such resilient foams are both porous to allow fluids to move therethrough and provide a comfortable fit between wearer and the device that does not cause sores. Engaging the retention means may include compressing the fluid collection device, disposing it in an undergarment of the wearer with the opening over the urethra, and allowing, the device to at least partially expand to the anatomy of the wearer.


In some examples, engaging the retention means includes manipulating the fluid collection device to pinch or bias against a portion of the anatomy of the wearer. In such examples, the retention means may be at least partially defined by the fluid impermeable barrier. For example, the fluid impermeable barrier defines labial flanges and lobes extending therefrom (FIGS. 9-10). In such examples, the fluid impermeable barrier converges to an apex along a longitudinal axis of a wearer facing side thereof. The labial flanges include at least semi-rigid longitudinally extending flanges having valleys sized and shaped to at least partially accommodate labia therein. The lobes extend longitudinally along at least a portion of a back side of the fluid impermeable barrier and include a valley therebetween. The lateral ends of the labial flanges rotate away from the apex when the lobes are pinched due to tension applied across the fluid impermeable barrier. Engaging the retention means of the fluid collection device may include bending or pinching the lobes of the fluid collection device and releasing the lobes when the labial flanges thereof are positioned on the labia of the wearer. As the lobes are released, the labial flanges may bias inward against the labia to compress against (e.g., pinch) the labia. Accordingly, the fluid collection device may be retained in place on the wearer by the labial flanges and apex. By locating the opening on the apex, the opening may be maintained in position over the urethra of the wearer.


In some examples, engaging the retention means may include adhering a portion of the fluid collection device to the wearer. For example, the retention means may include a mucoadhesive disposed on an outer surface of the fluid impermeable barrier in one or more regions thereon (FIGS. 11 and 12). In some examples, the one or more regions include a region bordering the opening, such as around one or more portions of the opening. Engaging the retention means includes placing the mucoadhesive of the fluid collection device in contact with the wearer, such as in contact with the inner thigh, labia, pubic region, perineal region, or the like.


In some examples, a combination of any of the retention means disclosed herein may be used together. In such examples, the engaging the retention means may include engaging multiple retention means as disclosed herein.


Receiving fluid in the fluid collection device may include receiving urine or any other fluid discharged from the wearer into the fluid collection device. The urine may be received by the porous material (such as passing from the fluid permeable membrane to the fluid permeable support). For example, receiving fluid into the fluid collection device includes receiving urine from a urethra of the wearer into the interior chamber, such as into the porous material through the opening. Receiving the fluid may include receiving the fluid into a reservoir of the fluid collection device. The fluid may be removed from the interior chamber, such as from the reservoir via the conduit therein.


The devices, systems, and methods disclosed herein provide for retention of the position of fluid collection devices with respect to the anatomy (e.g., urethra) of the wearer, thereby preventing spills of bodily fluids and soiling of beds and clothing. Such improved retention of position limits the amount of monitoring of immobile or bedbound patients to ensure the fluid collection device is in position. Such improvements limit the time that care or medical professionals need to devote for ensuring urine is not contaminating the patient, undergarments, clothing, bedding, or the like.


The method 600 may include removing the fluid from the fluid collection device via the conduit. Removing the fluid from the fluid collection device via the conduit may include applying a vacuum in the interior chamber, such as into the reservoir via the conduit. Removing the fluid from the fluid collection device via the conduit may include allowing fluid to be removed from interior chamber via gravity. Removing the fluid from the fluid collection device via the conduit may include removing the fluid into a fluid storage container, such as via vacuum or gravity feed.


While various aspects and embodiments have been disclosed herein, other aspects and embodiments are contemplated. The various aspects and embodiment disclosed herein are for purposes of illustration and are not intended to be limiting. Features from any of the disclosed embodiments may be used in combination with one another, without limitation.

Claims
  • 1. A fluid collection device, the fluid collection device comprising: a fluid impermeable barrier defining an interior chamber therein, an aperture, and an opening through which the interior chamber is accessible;a porous material disposed in the interior chamber;a conduit fluidly connected to the interior chamber and extending through the aperture, wherein the porous material define a space that accommodates the conduit; anda retention means for retaining positioning of the fluid collection device with respect to a wearer, the retention means at least one of: disposed in or on the conduit, the retention means disposed in or on the conduit disposed only in the space defined by the porous material;including a plurality of fibers disposed between an inner tubing and an outer tube, the plurality fibers configured to move pass each other when the inner tubing and the outer tubing is bent;including a resilient foam that is compressible, the resilient foam forming at least a portion of the porous material; orincluding labial flanges defined by the fluid impermeable barrier, the labial flanges include at least semi-rigid longitudinally extending flanges having valleys sized and shaped to at least partially accommodate labia therein.
  • 2. The device of claim 1 wherein the retention means includes a deformable conduit.
  • 3. The device of claim 2 wherein the deformable conduit includes gooseneck tubing having tubing disposed thereover.
  • 4. The device of claim 2 wherein the deformable conduit includes the plurality of fibers disposed between the inner tubing and the outer tube.
  • 5. The device of claim 4 wherein the plurality of fibers is concentrically sandwiched between the inner tubing and the outer tube.
  • 6. The device of claim 1 wherein; the retention means is at least partially defined by the porous material; andthe porous material includes the resilient foam that is compressible.
  • 7. The device of claim 6 wherein the resilient foam includes a memory foam.
  • 8. The device of claim 1 wherein: the fluid impermeable barrier defines the labial flanges and lobes extending therefrom;the fluid impermeable barrier converges to an apex along a longitudinal axis of a wearer facing side thereof;the lobes extend longitudinally along at least a portion of a back side of the fluid impermeable barrier and include a valley therebetween; andlateral ends of the labial flanges rotate away from the apex when the lobes are pinched due to tension applied across the fluid impermeable barrier.
  • 9. The device of claim 1 wherein the retention means includes a mucoadhesive disposed on an outer surface of the fluid impermeable barrier in one or more regions thereon.
  • 10. The device of claim 9 wherein the one or more regions include a region bordering the opening.
  • 11. A fluid collection system, comprising: a fluid storage container configured to hold a fluid;a fluid collection device fluidly coupled to the fluid storage container via a conduit, the fluid collection device including: a fluid impermeable barrier defining an interior chamber therein, an aperture, and an opening through which the interior chamber is accessible;a porous material disposed in the interior chamber;a conduit fluidly connected to the interior chamber and extending through the aperture, wherein the porous material define a space that accommodates the conduit; anda retention means for retaining positioning of the fluid collection device with respect to a wearer, the retention means at least one of: disposed in or on the conduit, the retention means disposed in or on the conduit disposed only in the space defined by the porous material;including a plurality of fibers disposed between an inner tubing and an outer tube, the plurality fibers configured to move pass each other when the inner tubing and the outer tubing is bent;including a resilient foam that is compressible, the resilient foam forming at least a portion of the porous material; orincluding labial flanges defined by the fluid impermeable barrier, the labial flanges include at least semi-rigid longitudinally extending flanges having valleys sized and shaped to at least partially accommodate labia therein; andat least one vacuum source fluidly coupled to the fluid storage container, the at least one vacuum source configured to draw fluid into the at least one fluid storage container from the fluid collection device via the conduit.
  • 12. The fluid collection system of claim 11 wherein the fluid storage container includes a canister.
  • 13. The fluid collection system of claim 11 wherein the vacuum source includes one or more of a vacuum pump, a wall-mounted vacuum line, or a hand pump.
  • 14. A method for collecting fluid, the method comprising: positioning a fluid collection device on a wearer, the fluid collection device including: a fluid impermeable barrier defining an interior chamber therein and an opening through which the interior chamber is accessible;a porous material disposed in the interior chamber; a conduit fluidly connected to the interior chamber; anda retention means for retaining positioning of the fluid collection device with respect to the wearer, the retention means at least one of: disposed in or on the conduit, the retention means disposed in or on the conduit disposed only in the space defined by the porous material;including a plurality of fibers disposed between an inner tubing and an outer tube, the plurality fibers configured to move pass each other when the inner tubing and the outer tubing is bent;including a resilient foam that is compressible, the resilient foam forming at least a portion of the porous material; orincluding labial flanges defined by the fluid impermeable barrier, the labial flanges include at least semi-rigid longitudinally extending flanges having valleys sized and shaped to at least partially accommodate labia therein;engaging the retention means of the fluid collection device; andreceiving fluid into the fluid collection device.
  • 15. The method of claim 14 wherein positioning the fluid collection device on a wearer includes positioning the opening over a urethra of the wearer.
  • 16. The method of claim 14 wherein: the retention means includes a deformable conduit; andengaging the retention means of the fluid collection device includes bending the deformable conduit to cause the fluid collection device to have an arcuate shape conforming to anatomy of the wearer.
  • 17. The method of claim 16 wherein the deformable conduit includes gooseneck tubing having tubing disposed thereover.
  • 18. The method of claim 16 wherein the deformable conduit includes the plurality of fibers disposed between the inner tubing and the outer tube.
  • 19. The method of claim 14 wherein: the retention means is at least partially defined by the porous material and the porous material includes the resilient foam that is compressible; andengaging the retention means of the fluid collection device includes one or more of compressing, shaping, or molding the fluid collection device to a compressed state and allowing the fluid collection device to at least partially expand against anatomy of the wearer.
  • 20. The method of claim 19 wherein the resilient foam includes a memory foam.
  • 21. The method of claim 14 wherein: the fluid impermeable barrier defines the labial flanges and lobes extending therefrom;the fluid impermeable barrier converges to an apex along a longitudinal axis of a wearer facing side thereof;the lobes extend longitudinally along at least a portion of a back side of the fluid impermeable barrier and include a valley therebetween; andlateral ends of the labial flanges rotate away from the apex when the lobes are pinched due to tension applied across the fluid impermeable barrier; andengaging the retention means of the fluid collection device includes bending or pinching the lobes of the fluid collection device and releasing the lobes when the labial flanges thereof are positioned on the labia of the wearer.
  • 22. The method of claim 14 wherein: the retention means includes a mucoadhesive disposed on an outer surface of the fluid impermeable barrier in one or more regions thereon; andthe retention means includes placing the mucoadhesive of the fluid collection device in contact with the wearer.
  • 23. The method of claim 22 wherein the one or more regions include a region bordering the opening.
  • 24. The method of claim 14 wherein receiving fluid into the fluid collection device includes receiving urine from a urethra of the wearer into the porous material.
  • 25. The method of claim 14 further comprising removing the fluid from the fluid collection device via the conduit.
  • 26. The method of claim 25 wherein removing the fluid from the fluid collection device via the conduit includes applying a vacuum in the interior chamber.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a U.S. Nationalization of PCT International Application No. PCT/US2022/012794 filed on Jan. 18, 2022, which claims priority to U.S. Provisional Patent Application No. 63/138,878 filed on 19 Jan. 2021, the disclosure of each of which is incorporated herein, in its entirety, by this references.

US Referenced Citations (753)
Number Name Date Kind
670602 Baker Mar 1901 A
1032841 Koenig Jul 1912 A
1178644 Johnson Apr 1916 A
1742080 Jones Dec 1929 A
1979899 O'Brien et al. Nov 1934 A
2262772 Peder Nov 1941 A
2326881 Packer Aug 1943 A
2379346 Farrell Jun 1945 A
2613670 Edward Oct 1952 A
2616426 Adele Nov 1952 A
2644234 Earl Jul 1953 A
2859786 Tupper Nov 1958 A
2968046 Duke Jan 1961 A
2971512 Reinhardt Feb 1961 A
3032038 Swinn May 1962 A
3077883 Hill Feb 1963 A
3087938 Hans et al. Apr 1963 A
3194238 Breece Jul 1965 A
3198994 Hildebrandt et al. Aug 1965 A
3221742 Egon Dec 1965 A
3312981 McGuire et al. Apr 1967 A
3349768 Keane Oct 1967 A
3362590 Gene Jan 1968 A
3366116 Huck Jan 1968 A
3398848 Donovan Aug 1968 A
3400717 Bruce et al. Sep 1968 A
3406688 Bruce Oct 1968 A
3424163 Gravdahl Jan 1969 A
3425471 Yates Feb 1969 A
3511241 Lee May 1970 A
3512185 Ellis May 1970 A
3520300 Flower Jul 1970 A
3528423 Lee Sep 1970 A
3613123 Langstrom Oct 1971 A
3648700 Warner Mar 1972 A
3651810 Ormerod Mar 1972 A
3661155 Lindan May 1972 A
3699815 Holbrook Oct 1972 A
3726277 Hirschman Apr 1973 A
3742952 Magers et al. Jul 1973 A
3757355 Allen et al. Sep 1973 A
3788324 Lim Jan 1974 A
3843016 Bornhorst et al. Oct 1974 A
3863638 Rogers et al. Feb 1975 A
3863798 Kurihara et al. Feb 1975 A
3864759 Horiuchi Feb 1975 A
3881486 Fenton May 1975 A
3915189 Holbrook et al. Oct 1975 A
3998228 Poidomani Dec 1976 A
3999550 Martin Dec 1976 A
4015604 Csillag Apr 1977 A
4020843 Kanall May 1977 A
4022213 Stein May 1977 A
4027776 Douglas Jun 1977 A
4116197 Bermingham Sep 1978 A
4180178 Turner Dec 1979 A
4187953 Turner Feb 1980 A
4194508 Anderson Mar 1980 A
4200102 Duhamel Apr 1980 A
4202058 Anderson May 1980 A
4233025 Larson et al. Nov 1980 A
4233978 Hickey Nov 1980 A
4246901 Frosch et al. Jan 1981 A
4257418 Hessner Mar 1981 A
4270539 Frosch Jun 1981 A
4281655 Terauchi Aug 1981 A
4292916 Bradley et al. Oct 1981 A
4352356 Tong Oct 1982 A
4360933 Kimura et al. Nov 1982 A
4365363 Windauer Dec 1982 A
4387726 Denard Jun 1983 A
4425130 Desmarais Jan 1984 A
4446986 Bowen et al. May 1984 A
4453938 Brendling Jun 1984 A
4457314 Knowles Jul 1984 A
4476879 Jackson Oct 1984 A
4526688 Schmidt et al. Jul 1985 A
4528703 Kraus Jul 1985 A
D280438 Wendt Sep 1985 S
4551141 McNeil Nov 1985 A
4553968 Komis Nov 1985 A
4581026 Schneider Apr 1986 A
4610675 Triunfol Sep 1986 A
4620333 Ritter Nov 1986 A
4626250 Schneider Dec 1986 A
4627846 Ternstroem Dec 1986 A
4631061 Martin Dec 1986 A
4650477 Johnson Mar 1987 A
4656675 Fajnsztajn Apr 1987 A
4681570 Dalton Jul 1987 A
4692160 Nussbaumer Sep 1987 A
4707864 Ikematsu et al. Nov 1987 A
4713066 Komis Dec 1987 A
4747166 Kuntz May 1988 A
4752944 Conrads et al. Jun 1988 A
4769215 Ehrenkranz Sep 1988 A
4772280 Rooyakkers Sep 1988 A
4790830 Hamacher Dec 1988 A
4790835 Elias Dec 1988 A
4791686 Taniguchi et al. Dec 1988 A
4795449 Schneider Jan 1989 A
4798603 Meyer et al. Jan 1989 A
4799928 Crowley Jan 1989 A
4804377 Hanifl et al. Feb 1989 A
4812053 Bhattacharjee Mar 1989 A
4820297 Kaufman et al. Apr 1989 A
4846818 Keldahl et al. Jul 1989 A
4846909 Klug et al. Jul 1989 A
4865595 Heyden Sep 1989 A
4882794 Stewart Nov 1989 A
4883465 Brennan Nov 1989 A
4886508 Washington Dec 1989 A
4886509 Mattsson Dec 1989 A
4889532 Metz et al. Dec 1989 A
4889533 Beecher Dec 1989 A
4903254 Haas Feb 1990 A
4905692 More Mar 1990 A
4936838 Cross et al. Jun 1990 A
4955922 Terauchi Sep 1990 A
4957487 Gerow Sep 1990 A
4965460 Tanaka et al. Oct 1990 A
4987849 Sherman Jan 1991 A
5002541 Conkling et al. Mar 1991 A
5004463 Nigay Apr 1991 A
5031248 Kemper Jul 1991 A
5045077 Blake Sep 1991 A
5045283 Patel Sep 1991 A
5049144 Payton Sep 1991 A
5053339 Patel Oct 1991 A
5058088 Haas et al. Oct 1991 A
5071347 McGuire Dec 1991 A
5078707 Peter Jan 1992 A
5084037 Barnett Jan 1992 A
5100396 Zamierowski Mar 1992 A
5147301 Ruvio Sep 1992 A
5195997 Carns Mar 1993 A
5203699 McGuire Apr 1993 A
5244458 Takasu Sep 1993 A
5246454 Peterson Sep 1993 A
5267988 Farkas Dec 1993 A
5275307 Freese Jan 1994 A
5294983 Ersoz et al. Mar 1994 A
5295983 Kubo Mar 1994 A
5300052 Kubo Apr 1994 A
5312383 Kubalak May 1994 A
5318550 Cermak et al. Jun 1994 A
5340840 Park et al. Aug 1994 A
5382244 Telang Jan 1995 A
5423784 Metz Jun 1995 A
5466229 Elson Nov 1995 A
5478334 Bernstein Dec 1995 A
5499977 Marx Mar 1996 A
5543042 Filan et al. Aug 1996 A
D373928 Green Sep 1996 S
5605161 Cross Feb 1997 A
5618277 Goulter Apr 1997 A
5628735 Skow May 1997 A
5636643 Argenta et al. Jun 1997 A
5637104 Ball et al. Jun 1997 A
5674212 Osborn, III Oct 1997 A
5678564 Lawrence Oct 1997 A
5678654 Uzawa Oct 1997 A
5687429 Rahlff Nov 1997 A
5695485 Duperret et al. Dec 1997 A
5752944 Dann et al. May 1998 A
5772644 Bark et al. Jun 1998 A
5792132 Garcia Aug 1998 A
5827243 Palestrant Oct 1998 A
5827247 Kay Oct 1998 A
5827250 Fujioka et al. Oct 1998 A
5827257 Fujioka et al. Oct 1998 A
D401699 Herchenbach et al. Nov 1998 S
5865378 Hollinshead et al. Feb 1999 A
5887291 Bellizzi Mar 1999 A
5894608 Birbara Apr 1999 A
D409303 Oepping May 1999 S
5911222 Lawrence Jun 1999 A
5957904 Holland Sep 1999 A
5972505 Phillips et al. Oct 1999 A
6050983 Moore et al. Apr 2000 A
6059762 Boyer et al. May 2000 A
6063064 Tuckey et al. May 2000 A
6098625 Winkler Aug 2000 A
6105174 Karlsten et al. Aug 2000 A
6113582 Dwork Sep 2000 A
6117163 Bierman Sep 2000 A
6123398 Arai Sep 2000 A
6129718 Wada et al. Oct 2000 A
6131964 Sareshwala Oct 2000 A
6152902 Christian et al. Nov 2000 A
6164569 Hollinshead et al. Dec 2000 A
6177606 Etheredge et al. Jan 2001 B1
6209142 Mattsson et al. Apr 2001 B1
6248096 Dwork et al. Jun 2001 B1
6263887 Dunn Jul 2001 B1
6311339 Kraus Nov 2001 B1
6336919 Davis et al. Jan 2002 B1
6338729 Wada et al. Jan 2002 B1
6352525 Wakabayashi Mar 2002 B1
6394988 Hashimoto May 2002 B1
6406463 Brown Jun 2002 B1
6409712 Dutari et al. Jun 2002 B1
6416500 Wada et al. Jul 2002 B1
6428521 Droll Aug 2002 B1
6475198 Lipman et al. Nov 2002 B1
6479726 Cole et al. Nov 2002 B1
6491673 Palumbo et al. Dec 2002 B1
6508794 Palumbo et al. Jan 2003 B1
6540729 Wada et al. Apr 2003 B1
6547771 Robertson et al. Apr 2003 B2
6569133 Cheng et al. May 2003 B2
D476518 Doppelt Jul 2003 S
6592560 Snyder et al. Jul 2003 B2
6618868 Minnick Sep 2003 B2
6620142 Flueckiger Sep 2003 B1
6629651 Male et al. Oct 2003 B1
6635038 Scovel Oct 2003 B2
6652495 Walker Nov 2003 B1
6685684 Falconer Feb 2004 B1
6702793 Sweetser et al. Mar 2004 B1
6706027 Harvie Mar 2004 B2
6732384 Scott May 2004 B2
6736977 Hall et al. May 2004 B1
6740066 Wolff May 2004 B2
6764477 Chen et al. Jul 2004 B1
6783519 Samuelsson Aug 2004 B2
6796974 Palumbo et al. Sep 2004 B2
6814547 Childers et al. Nov 2004 B2
6849065 Schmidt et al. Feb 2005 B2
6857137 Otto Feb 2005 B2
6885690 Aggerstam et al. Apr 2005 B2
6888044 Fell et al. May 2005 B2
6893425 Dunn et al. May 2005 B2
6912737 Ernest et al. Jul 2005 B2
6918899 Harvie Jul 2005 B2
6979324 Bybordi et al. Dec 2005 B2
7018366 Easter Mar 2006 B2
7066411 Male et al. Jun 2006 B2
7122023 Hinoki Oct 2006 B1
7125399 Miskie Oct 2006 B2
7131964 Harvie Nov 2006 B2
7135012 Harvie Nov 2006 B2
7141043 Harvie Nov 2006 B2
D533972 La Luzerne Dec 2006 S
7160273 Greter et al. Jan 2007 B2
7171699 Ernest et al. Feb 2007 B2
7171871 Kozak Feb 2007 B2
7179951 Krishnaswamy-Mirle et al. Feb 2007 B2
7181781 Trabold Feb 2007 B1
7186245 Cheng et al. Mar 2007 B1
7192424 Cooper Mar 2007 B2
7220250 Suzuki May 2007 B2
D562975 Otto Feb 2008 S
7335189 Harvie Feb 2008 B2
7358282 Krueger et al. Apr 2008 B2
7390320 Machida Jun 2008 B2
7438706 Koizumi et al. Oct 2008 B2
7488310 Yang Feb 2009 B2
7491194 Oliwa Feb 2009 B1
D591106 Dominique et al. Apr 2009 S
7513381 Heng et al. Apr 2009 B2
7520872 Biggie et al. Apr 2009 B2
D593801 Wilson et al. Jun 2009 S
7540364 Sanderson Jun 2009 B2
7585293 Vermaak Sep 2009 B2
7588560 Dunlop Sep 2009 B1
7665359 Barber Feb 2010 B2
7682347 Parks et al. Mar 2010 B2
7687004 Allen Mar 2010 B2
7695459 Gilbert et al. Apr 2010 B2
7695460 Wada et al. Apr 2010 B2
7699818 Gilbert Apr 2010 B2
7699831 Bengtson Apr 2010 B2
7722584 Tanaka et al. May 2010 B2
7727206 Gorres Jun 2010 B2
7740620 Gilbert et al. Jun 2010 B2
7749205 Tazoe Jul 2010 B2
7755497 Wada Jul 2010 B2
7766887 Burns et al. Aug 2010 B2
D625407 Koizumi et al. Oct 2010 S
7806879 Brooks et al. Oct 2010 B2
7811272 Lindsay et al. Oct 2010 B2
7815067 Matsumoto et al. Oct 2010 B2
7833169 Hannon Nov 2010 B2
7857806 Karpowicz et al. Dec 2010 B2
7866942 Harvie Jan 2011 B2
7871385 Levinson et al. Jan 2011 B2
7875010 Frazier et al. Jan 2011 B2
7901389 Mombrinie Mar 2011 B2
7927320 Goldwasser et al. Apr 2011 B2
7927321 Marland Apr 2011 B2
7931634 Swiecicki et al. Apr 2011 B2
7939706 Okabe et al. May 2011 B2
7946443 Stull et al. May 2011 B2
7947025 Buglino et al. May 2011 B2
7963419 Burney et al. Jun 2011 B2
7976519 Bubb et al. Jul 2011 B2
7993318 Olsson et al. Aug 2011 B2
8015627 Baker et al. Sep 2011 B2
8028460 Williams Oct 2011 B2
8047398 Dimartino et al. Nov 2011 B2
8083094 Caulfield et al. Dec 2011 B2
8128608 Thevenin Mar 2012 B2
8181651 Pinel May 2012 B2
8181819 Burney et al. May 2012 B2
8211063 Bierman Jul 2012 B2
8221369 Parks et al. Jul 2012 B2
8241262 Mahnensmith Aug 2012 B2
8277426 Wilcox et al. Oct 2012 B2
8287508 Sanchez Oct 2012 B1
8303554 Tsai et al. Nov 2012 B2
8322565 Caulfield et al. Dec 2012 B2
8337477 Parks et al. Dec 2012 B2
D674241 Bickert et al. Jan 2013 S
8343122 Gorres Jan 2013 B2
8353074 Krebs Jan 2013 B2
8353886 Bester et al. Jan 2013 B2
D676241 Merrill Feb 2013 S
8388588 Wada et al. Mar 2013 B2
D679807 Burgess et al. Apr 2013 S
8425482 Khoubnazar Apr 2013 B2
8449510 Martini et al. May 2013 B2
D684260 Lund et al. Jun 2013 S
8470230 Caulfield et al. Jun 2013 B2
8479941 Matsumoto et al. Jul 2013 B2
8479949 Henkel Jul 2013 B2
8512301 Ma Aug 2013 B2
8529530 Koch et al. Sep 2013 B2
8535284 Joder et al. Sep 2013 B2
8546639 Wada Oct 2013 B2
8551075 Bengtson Oct 2013 B2
8568376 Delattre et al. Oct 2013 B2
D694404 Burgess et al. Nov 2013 S
8585683 Bengtson Nov 2013 B2
8586583 Hamblin et al. Nov 2013 B2
8652112 Johannison et al. Feb 2014 B2
D702973 Norland et al. Apr 2014 S
8703032 Menon et al. Apr 2014 B2
D704330 Cicatelli May 2014 S
D704510 Mason et al. May 2014 S
D705423 Walsh Cutler May 2014 S
D705926 Burgess et al. May 2014 S
8714394 Wulf May 2014 B2
8715267 Bengtson et al. May 2014 B2
8757425 Copeland Jun 2014 B2
8777032 Biesecker et al. Jul 2014 B2
8808260 Koch et al. Aug 2014 B2
8864730 Conway et al. Oct 2014 B2
8881923 Higginson Nov 2014 B2
8936585 Carson et al. Jan 2015 B2
D729581 Boroski May 2015 S
9028460 Medeiros May 2015 B2
9056698 Noer Jun 2015 B2
9078792 Ruiz Jul 2015 B2
9173602 Gilbert Nov 2015 B2
9173799 Tanimoto Nov 2015 B2
9187220 Biesecker et al. Nov 2015 B2
9199772 Krippendorf Dec 2015 B2
9233020 Matsumiya Jan 2016 B2
9248058 Conway et al. Feb 2016 B2
9308118 Dupree et al. Apr 2016 B1
9309029 Incorvia et al. Apr 2016 B2
9333281 Giezendanner et al. May 2016 B2
9382047 Schmidtner et al. Jul 2016 B2
9456937 Ellis Oct 2016 B2
9480595 Baham et al. Nov 2016 B2
9517865 Albers et al. Dec 2016 B2
D777941 Piramoon Jan 2017 S
9533806 Ding et al. Jan 2017 B2
9550611 Hodge Jan 2017 B2
9555930 Campbell et al. Jan 2017 B2
D789522 Burgess et al. Jun 2017 S
9687849 Bruno et al. Jun 2017 B2
9694949 Hendricks et al. Jul 2017 B2
9788992 Harvie Oct 2017 B2
D804907 Sandoval Dec 2017 S
9868564 McGirr et al. Jan 2018 B2
D814239 Arora Apr 2018 S
D817484 Lafond May 2018 S
10037640 Gordon Jul 2018 B2
10058470 Phillips Aug 2018 B2
10098990 Koch et al. Oct 2018 B2
D835264 Mozzicato et al. Dec 2018 S
D835779 Mozzicato et al. Dec 2018 S
D840533 Mozzicato et al. Feb 2019 S
D840534 Mozzicato et al. Feb 2019 S
10225376 Perez Martinez Mar 2019 B2
10226376 Sanchez Mar 2019 B2
D848612 Mozzicato et al. May 2019 S
10307305 Hodges Jun 2019 B1
10335121 Desai Jul 2019 B2
D856512 Cowart et al. Aug 2019 S
10376406 Newton Aug 2019 B2
10376407 Newton Aug 2019 B2
10390989 Sanchez Aug 2019 B2
D858144 Fu Sep 2019 S
10406039 Villarreal Sep 2019 B2
10407222 Allen Sep 2019 B2
10478356 Griffin Nov 2019 B2
10538366 Pentelovitch et al. Jan 2020 B2
10569938 Zhao et al. Feb 2020 B2
10577156 Dagnelie et al. Mar 2020 B2
10618721 Vazin Apr 2020 B2
D884390 Wang May 2020 S
10669079 Freedman et al. Jun 2020 B2
D892315 Airy Aug 2020 S
10730672 Bertram et al. Aug 2020 B2
10737848 Philip et al. Aug 2020 B2
10765854 Law et al. Sep 2020 B2
10766670 Kittmann Sep 2020 B2
D901214 Hu Nov 2020 S
10857025 Davis et al. Dec 2020 B2
10865017 Cowart et al. Dec 2020 B1
10889412 West et al. Jan 2021 B2
10913581 Stahlecker Feb 2021 B2
D912244 Rehm et al. Mar 2021 S
10952889 Newton Mar 2021 B2
10973678 Newton Apr 2021 B2
10974874 Ragias et al. Apr 2021 B2
11000401 Ecklund et al. May 2021 B2
D923365 Wang Jun 2021 S
11026829 Harvie Jun 2021 B2
11027900 Liu Jun 2021 B2
11045346 Argent et al. Jun 2021 B2
D928946 Sanchez Aug 2021 S
11179506 Barr et al. Nov 2021 B2
11226376 Yamauchi et al. Jan 2022 B2
11376152 Sanchez Jul 2022 B2
11382786 Sanchez Jul 2022 B2
11382788 Hjorth et al. Jul 2022 B2
11426303 Davis Aug 2022 B2
11529252 Glithero et al. Dec 2022 B2
20010037097 Cheng et al. Nov 2001 A1
20010054426 Knudson et al. Dec 2001 A1
20020019614 Woon Feb 2002 A1
20020026161 Grundke Feb 2002 A1
20020087131 Wolff Jul 2002 A1
20020091364 Prabhakar Jul 2002 A1
20020189992 Schmidt et al. Dec 2002 A1
20020193760 Thompson Dec 2002 A1
20030004436 Schmidt et al. Jan 2003 A1
20030120178 Heki Jun 2003 A1
20030157859 Ishikawa Aug 2003 A1
20030181880 Schwartz Sep 2003 A1
20030195484 Harvie Oct 2003 A1
20030233079 Parks et al. Dec 2003 A1
20040006321 Cheng et al. Jan 2004 A1
20040056122 Male et al. Mar 2004 A1
20040084465 Luburic May 2004 A1
20040127872 Petryk Jul 2004 A1
20040128749 Scott Jul 2004 A1
20040143229 Easter Jul 2004 A1
20040147894 Mizutani et al. Jul 2004 A1
20040158221 Mizutani et al. Aug 2004 A1
20040176731 Cheng et al. Sep 2004 A1
20040191919 Unger et al. Sep 2004 A1
20040207530 Nielsen Oct 2004 A1
20040236292 Tazoe Nov 2004 A1
20040254547 Okabe Dec 2004 A1
20050010182 Parks et al. Jan 2005 A1
20050033248 Machida Feb 2005 A1
20050070861 Okabe Mar 2005 A1
20050070862 Tazoe Mar 2005 A1
20050082300 Modrell et al. Apr 2005 A1
20050097662 Leimkuhler et al. May 2005 A1
20050101924 Elson et al. May 2005 A1
20050137557 Swiecicki et al. Jun 2005 A1
20050154360 Harvie Jul 2005 A1
20050177070 Levinson et al. Aug 2005 A1
20050197639 Mombrinie Sep 2005 A1
20050273920 Marinas Dec 2005 A1
20050277904 Chase et al. Dec 2005 A1
20050279359 Leblanc et al. Dec 2005 A1
20060004332 Marx Jan 2006 A1
20060015080 Mahnensmith Jan 2006 A1
20060015081 Suzuki Jan 2006 A1
20060016778 Park Jan 2006 A1
20060079854 Kay et al. Apr 2006 A1
20060111648 Vermaak May 2006 A1
20060155214 Wightman Jul 2006 A1
20060200102 Cooper Sep 2006 A1
20060229576 Conway et al. Oct 2006 A1
20060231648 Male et al. Oct 2006 A1
20060235359 Marland Oct 2006 A1
20060277670 Baker et al. Dec 2006 A1
20070006368 Key et al. Jan 2007 A1
20070038194 Wada Feb 2007 A1
20070055209 Patel et al. Mar 2007 A1
20070073252 Forgrave Mar 2007 A1
20070117880 Elson et al. May 2007 A1
20070135786 Schmidt et al. Jun 2007 A1
20070149935 Dirico Jun 2007 A1
20070191804 Coley Aug 2007 A1
20070214553 Carromba Sep 2007 A1
20070225666 Otto Sep 2007 A1
20070225668 Otto Sep 2007 A1
20070266486 Ramirez Nov 2007 A1
20070282309 Bengtson et al. Dec 2007 A1
20080004576 Tanaka et al. Jan 2008 A1
20080015526 Reiner et al. Jan 2008 A1
20080015527 House Jan 2008 A1
20080033386 Okabe Feb 2008 A1
20080041869 Backaert Feb 2008 A1
20080091153 Harvie Apr 2008 A1
20080091158 Yang Apr 2008 A1
20080183157 Walters Jul 2008 A1
20080215031 Belfort et al. Sep 2008 A1
20080234642 Patterson et al. Sep 2008 A1
20080281282 Finger et al. Nov 2008 A1
20080287894 Van Den Heuvel Nov 2008 A1
20090025717 Pinel Jan 2009 A1
20090048570 Jensen Feb 2009 A1
20090056003 Ivie et al. Mar 2009 A1
20090069761 Vogel Mar 2009 A1
20090069765 Wortham Mar 2009 A1
20090192482 Dodge, II Jul 2009 A1
20090234312 O'Toole et al. Sep 2009 A1
20090251510 Noro et al. Oct 2009 A1
20090264840 Virginio Oct 2009 A1
20090270822 Medeiros Oct 2009 A1
20090281510 Fisher Nov 2009 A1
20100004612 Thevenin Jan 2010 A1
20100058660 Williams Mar 2010 A1
20100121289 Parks et al. May 2010 A1
20100158168 Murthy et al. Jun 2010 A1
20100185168 Graauw Jul 2010 A1
20100198172 Wada et al. Aug 2010 A1
20100211032 Tsai Aug 2010 A1
20100234820 Tsai et al. Sep 2010 A1
20100241104 Gilbert Sep 2010 A1
20100263113 Shelton et al. Oct 2010 A1
20100310845 Bond et al. Dec 2010 A1
20110028922 Kay et al. Feb 2011 A1
20110034889 Smith Feb 2011 A1
20110036837 Shang Feb 2011 A1
20110040267 Wada Feb 2011 A1
20110040271 Rogers Feb 2011 A1
20110054426 Stewart et al. Mar 2011 A1
20110060300 Weig Mar 2011 A1
20110077495 Gilbert Mar 2011 A1
20110077606 Wilcox et al. Mar 2011 A1
20110087337 Forsell Apr 2011 A1
20110137273 Muellejans et al. Jun 2011 A1
20110145993 Rader et al. Jun 2011 A1
20110152802 DiCamillo et al. Jun 2011 A1
20110164147 Takahashi et al. Jul 2011 A1
20110172620 Khambatta Jul 2011 A1
20110172625 Wada Jul 2011 A1
20110202024 Cozzens Aug 2011 A1
20110238023 Slayton Sep 2011 A1
20110240648 Tucker Oct 2011 A1
20110251572 Nishtala et al. Oct 2011 A1
20110265889 Tanaka et al. Nov 2011 A1
20110276020 Mitsui Nov 2011 A1
20120035577 Tomes et al. Feb 2012 A1
20120041400 Christensen Feb 2012 A1
20120059328 Dikeman et al. Mar 2012 A1
20120066825 Birbara et al. Mar 2012 A1
20120103347 Wheaton May 2012 A1
20120137420 Gordon et al. Jun 2012 A1
20120165768 Sekiyama et al. Jun 2012 A1
20120165786 Chappa et al. Jun 2012 A1
20120210503 Anzivino, Sr. Aug 2012 A1
20120233761 Huang Sep 2012 A1
20120245542 Suzuki Sep 2012 A1
20120245547 Wilcox et al. Sep 2012 A1
20120253303 Suzuki Oct 2012 A1
20120271259 Ulert Oct 2012 A1
20120296305 Barraza Khaled et al. Nov 2012 A1
20120330256 Wilcox et al. Dec 2012 A1
20130006206 Wada Jan 2013 A1
20130045651 Esteves et al. Feb 2013 A1
20130053804 Soerensen et al. Feb 2013 A1
20130096523 Chang et al. Apr 2013 A1
20130245496 Wells et al. Sep 2013 A1
20130245586 Jha Sep 2013 A1
20130292537 Dirico Nov 2013 A1
20140031774 Bengtson Jan 2014 A1
20140157499 Suzuki et al. Jun 2014 A1
20140182051 Tanimoto Jul 2014 A1
20140196189 Lee et al. Jul 2014 A1
20140276501 Cisko Sep 2014 A1
20140303582 Wright et al. Oct 2014 A1
20140316381 Reglin Oct 2014 A1
20140325746 Block Nov 2014 A1
20140348139 Gomez Martinez Nov 2014 A1
20140352050 Yao et al. Dec 2014 A1
20140371628 Desai Dec 2014 A1
20150045757 Lee et al. Feb 2015 A1
20150047114 Ramirez Feb 2015 A1
20150048089 Robertson Feb 2015 A1
20150135423 Sharpe et al. May 2015 A1
20150157300 Ealovega et al. Jun 2015 A1
20150209194 Heyman Jul 2015 A1
20150290425 Macy et al. Oct 2015 A1
20150320583 Harvie Nov 2015 A1
20150329255 Rzepecki Nov 2015 A1
20150359660 Harvie Dec 2015 A1
20150366699 Nelson Dec 2015 A1
20160029998 Brister et al. Feb 2016 A1
20160030228 Jones Feb 2016 A1
20160038356 Yao et al. Feb 2016 A1
20160058322 Brister et al. Mar 2016 A1
20160060001 Wada et al. Mar 2016 A1
20160100976 Conway et al. Apr 2016 A1
20160106604 Timm Apr 2016 A1
20160113809 Kim Apr 2016 A1
20160183689 Miner Jun 2016 A1
20160256022 Le Sep 2016 A1
20160270982 Raycheck et al. Sep 2016 A1
20160278662 Brister et al. Sep 2016 A1
20160357400 Penha et al. Dec 2016 A1
20160366699 Zhang et al. Dec 2016 A1
20160367226 Newton Dec 2016 A1
20160367411 Justiz et al. Dec 2016 A1
20160367726 Gratzer Dec 2016 A1
20160374848 Sanchez Dec 2016 A1
20170007438 Harvie Jan 2017 A1
20170100276 Joh Apr 2017 A1
20170128638 Giezendanner et al. May 2017 A1
20170143534 Sanchez May 2017 A1
20170165405 Muser et al. Jun 2017 A1
20170189225 Voorhees et al. Jul 2017 A1
20170202692 Laniado Jul 2017 A1
20170216081 Accosta Aug 2017 A1
20170246026 Laniado Aug 2017 A1
20170252014 Siller Gonzalez et al. Sep 2017 A1
20170252202 Sanchez et al. Sep 2017 A9
20170266031 Sanchez Sep 2017 A1
20170266658 Bruno et al. Sep 2017 A1
20170281399 VanMiddendorp Oct 2017 A1
20170312116 Laniado Nov 2017 A1
20170325788 Ealovega et al. Nov 2017 A1
20170333244 Laniado Nov 2017 A1
20170042748 Griffin Dec 2017 A1
20170348139 Newton Dec 2017 A1
20170354532 Holt Dec 2017 A1
20170367873 Grannum Dec 2017 A1
20180002075 Lee Jan 2018 A1
20180008451 Stroebech Jan 2018 A1
20180008804 Laniado Jan 2018 A1
20180028349 Newton Feb 2018 A1
20180037384 Archeny et al. Feb 2018 A1
20180049910 Newton Feb 2018 A1
20180064572 Wiltshire Mar 2018 A1
20180104131 Killian Apr 2018 A1
20180127187 Sewell May 2018 A1
20180193215 Davies et al. Jul 2018 A1
20180200101 Su Jul 2018 A1
20180228642 Davis Aug 2018 A1
20180256384 Kasirye Sep 2018 A1
20180271694 Fernandez et al. Sep 2018 A1
20190001030 Braga et al. Jan 2019 A1
20190021899 Vlet Jan 2019 A1
20190038451 Harvie Feb 2019 A1
20190046102 Kushnir et al. Feb 2019 A1
20190100362 Meyers et al. Apr 2019 A1
20190133814 Tammen et al. May 2019 A1
20190142624 Sanchez May 2019 A1
20190224036 Sanchez Jul 2019 A1
20190247222 Ecklund et al. Aug 2019 A1
20190247223 Brun et al. Aug 2019 A1
20190282391 Johannes et al. Sep 2019 A1
20190314189 Acosta Oct 2019 A1
20190314190 Sanchez Oct 2019 A1
20190344934 Faerber et al. Nov 2019 A1
20190365307 Laing et al. Dec 2019 A1
20190365561 Newton et al. Dec 2019 A1
20200030595 Boukidjian et al. Jan 2020 A1
20200046544 Godinez Feb 2020 A1
20200055638 Lau et al. Feb 2020 A1
20200070392 Huber et al. Mar 2020 A1
20200085610 Cohn et al. Mar 2020 A1
20200086090 Von Weymarn-Schärli et al. Mar 2020 A1
20200129322 Leuckel Apr 2020 A1
20200171217 Braga et al. Jun 2020 A9
20200229964 Staali et al. Jul 2020 A1
20200231343 Freedman et al. Jul 2020 A1
20200232841 Satish et al. Jul 2020 A1
20200255189 Liu Aug 2020 A1
20200261280 Heyman Aug 2020 A1
20200276046 Staali et al. Sep 2020 A1
20200306075 Newton et al. Oct 2020 A1
20200315838 Eckert Oct 2020 A1
20200331672 Bertram et al. Oct 2020 A1
20200345332 Duval Nov 2020 A1
20200353135 Gregory et al. Nov 2020 A1
20200367677 Silsby et al. Nov 2020 A1
20200369444 Silsby et al. Nov 2020 A1
20200375781 Staali et al. Dec 2020 A1
20200385179 McCourt Dec 2020 A1
20200390591 Glithero et al. Dec 2020 A1
20200390592 Merrill Dec 2020 A1
20200405521 Glasroe Dec 2020 A1
20210008771 Huber et al. Jan 2021 A1
20210009323 Markarian et al. Jan 2021 A1
20210061523 Bytheway Mar 2021 A1
20210069005 Sanchez Mar 2021 A1
20210069008 Blabas et al. Mar 2021 A1
20210113749 Radl et al. Apr 2021 A1
20210121318 Pinlac Apr 2021 A1
20210137724 Ecklund et al. May 2021 A1
20210154055 Villarreal May 2021 A1
20210170079 Radl et al. Jun 2021 A1
20210220162 Jamison Jul 2021 A1
20210220163 Mayrand Jul 2021 A1
20210228400 Glithero Jul 2021 A1
20210228401 Becker et al. Jul 2021 A1
20210228795 Hughett Jul 2021 A1
20210229877 Ragias et al. Jul 2021 A1
20210236323 Austermann Aug 2021 A1
20210267787 Nazemi Sep 2021 A1
20210315727 Jiang Oct 2021 A1
20210353450 Sharma et al. Nov 2021 A1
20210361469 Liu et al. Nov 2021 A1
20210369495 Cheng Dec 2021 A1
20210386925 Hartwell et al. Dec 2021 A1
20210393433 Godinez et al. Dec 2021 A1
20220023091 Ecklund et al. Jan 2022 A1
20220047410 Walthall Feb 2022 A1
20220062027 Mitchell et al. Mar 2022 A1
20220062029 Johannes Mar 2022 A1
20220066825 Saraf et al. Mar 2022 A1
20220071811 Cheng et al. Mar 2022 A1
20220104965 Vaninetti et al. Apr 2022 A1
20220104981 Jones Apr 2022 A1
20220117774 Meyer et al. Apr 2022 A1
20220117775 Jones Apr 2022 A1
20220133524 Davis May 2022 A1
20220151817 Mann May 2022 A1
20220218510 Metzger et al. Jul 2022 A1
20220229053 Levin et al. Jul 2022 A1
20220248836 Cagle et al. Aug 2022 A1
20220257407 Johannes Aug 2022 A1
20220265462 Alder Aug 2022 A1
20220273482 Johannes et al. Sep 2022 A1
20220280357 Jagannathan Sep 2022 A1
20220313474 Kriscovich et al. Oct 2022 A1
20220354685 Davis et al. Nov 2022 A1
20220370231 Wang et al. Nov 2022 A1
20220370234 Hughett Nov 2022 A1
20220370237 Parmar et al. Nov 2022 A1
20220387001 Askenazi et al. Dec 2022 A1
20220395391 Saunders Dec 2022 A1
20230018845 Lee Jan 2023 A1
20230020563 Sharma et al. Jan 2023 A1
20230037159 Brennan Feb 2023 A1
20230062944 Vollenberg et al. Mar 2023 A1
20230062994 Ecklund et al. Mar 2023 A1
20230089032 Hughett Mar 2023 A1
20230105001 Whittome et al. Apr 2023 A1
20230138269 Abdelal May 2023 A1
20230145365 Martin et al. May 2023 A1
Foreign Referenced Citations (326)
Number Date Country
2018216821 Aug 2019 AU
2165286 Sep 1999 CA
2354132 Jun 2000 CA
2488867 Aug 2007 CA
3050918 Aug 2018 CA
3098571 Nov 2019 CA
2269203 Dec 1997 CN
1332620 Jan 2002 CN
1533755 Oct 2004 CN
1602825 Apr 2005 CN
1720888 Jan 2006 CN
2936204 Aug 2007 CN
101262836 Sep 2008 CN
102159159 Aug 2011 CN
202184840 Apr 2012 CN
102481441 May 2012 CN
103533968 Jan 2014 CN
103717180 Apr 2014 CN
204562697 Aug 2015 CN
105451693 Mar 2016 CN
205849719 Jan 2017 CN
107847384 Mar 2018 CN
107920912 Apr 2018 CN
209285902 Aug 2019 CN
211198839 Aug 2020 CN
116096332 May 2023 CN
79818 Oct 1893 DE
1516466 Jun 1969 DE
2721330 Nov 1977 DE
2742298 Mar 1978 DE
9407554.9 May 1995 DE
4443710 Jun 1995 DE
19619597 Nov 1997 DE
102011103783 Dec 2012 DE
202015104597 Jul 2016 DE
9600118 Nov 1996 DK
0032138 Jul 1981 EP
0066070 Dec 1982 EP
0119143 Nov 1988 EP
0610638 Aug 1994 EP
0613355 Sep 1994 EP
0613355 Jan 1997 EP
0966936 Dec 1999 EP
0987293 Mar 2000 EP
1063953 Jan 2001 EP
0653928 Oct 2002 EP
1332738 Aug 2003 EP
1382318 Jan 2004 EP
1089684 Oct 2004 EP
1616542 Jan 2006 EP
1382318 May 2006 EP
1063953 Jan 2007 EP
1872752 Jan 2008 EP
2180907 May 2010 EP
2380532 Oct 2011 EP
2389908 Nov 2011 EP
2601916 Jun 2013 EP
2676643 Dec 2013 EP
2997950 Mar 2016 EP
2879534 Mar 2017 EP
3424471 Jan 2019 EP
3169292 Nov 2019 EP
3788992 Mar 2021 EP
3576689 Mar 2022 EP
3752110 Mar 2022 EP
4025163 Jul 2022 EP
1011517 Dec 1965 GB
1467144 Mar 1977 GB
2106395 Apr 1983 GB
2106784 Apr 1983 GB
2148126 May 1985 GB
2171315 Aug 1986 GB
2148126 Jul 1987 GB
2191095 Dec 1987 GB
2199750 Jul 1988 GB
2260907 May 1993 GB
2462267 Feb 2010 GB
2469496 Oct 2010 GB
2490327 Oct 2012 GB
2507318 Apr 2014 GB
201800009129 Apr 2020 IT
S5410596 Jan 1979 JP
S5410596 May 1979 JP
S55155618 Dec 1980 JP
S5888596 Jun 1983 JP
S63107780 Jul 1988 JP
H0267530 Mar 1990 JP
H02103871 Apr 1990 JP
H02131422 May 1990 JP
H0460220 Feb 1992 JP
H05123349 May 1993 JP
H05123350 May 1993 JP
3087938 Oct 1995 JP
H085630 Jan 1996 JP
H1040141 Feb 1998 JP
H10225430 Aug 1998 JP
H11113946 Apr 1999 JP
H11290365 Oct 1999 JP
2000116690 Apr 2000 JP
2000185068 Jul 2000 JP
2001054531 Feb 2001 JP
2001070331 Mar 2001 JP
2001276107 Oct 2001 JP
2001276108 Oct 2001 JP
2002028173 Jan 2002 JP
2003505152 Feb 2003 JP
2003180722 Jul 2003 JP
2004130056 Apr 2004 JP
2004267530 Sep 2004 JP
2005066011 Mar 2005 JP
2005066325 Mar 2005 JP
2005518237 Jun 2005 JP
3749097 Dec 2005 JP
2006026108 Feb 2006 JP
3123547 Jun 2006 JP
2006136492 Jun 2006 JP
2006204868 Aug 2006 JP
3132659 May 2007 JP
4039641 Nov 2007 JP
2009509570 Mar 2009 JP
2010081981 Apr 2010 JP
4640772 Dec 2010 JP
2010536439 Dec 2010 JP
4747166 May 2011 JP
2011087823 May 2011 JP
4801218 Aug 2011 JP
2011218130 Nov 2011 JP
2011224070 Nov 2011 JP
2012523869 Oct 2012 JP
2013238608 Nov 2013 JP
2014521960 Aug 2014 JP
2015092945 May 2015 JP
3198994 Jul 2015 JP
2019525811 Sep 2019 JP
2021120686 Aug 2021 JP
200290061 Sep 2002 KR
20030047451 Jun 2003 KR
20140039485 Apr 2014 KR
101432639 Aug 2014 KR
20180106659 Oct 2018 KR
20180108774 Oct 2018 KR
2068717 Jun 2013 PT
8101957 Jul 1981 WO
8804558 Jun 1988 WO
9104714 Apr 1991 WO
9104714 Jun 1991 WO
9220299 Feb 1993 WO
9309736 May 1993 WO
9309736 Jun 1993 WO
9514448 Jun 1995 WO
9600096 Jan 1996 WO
9634636 Nov 1996 WO
9817211 Apr 1998 WO
9830336 Jul 1998 WO
0000112 Jan 2000 WO
0000113 Jan 2000 WO
0025651 May 2000 WO
0033773 Jun 2000 WO
0057784 Oct 2000 WO
0145618 Jun 2001 WO
0145621 Jun 2001 WO
02094160 Nov 2002 WO
03013967 Feb 2003 WO
03024824 Mar 2003 WO
03055423 Jul 2003 WO
03071931 Sep 2003 WO
03079942 Oct 2003 WO
03071931 Feb 2004 WO
2004019836 Mar 2004 WO
2004024046 Mar 2004 WO
2005074571 Sep 2005 WO
2005089687 Sep 2005 WO
2005107661 Nov 2005 WO
2006021220 Mar 2006 WO
2007007845 Jan 2007 WO
2007042823 Apr 2007 WO
2007055651 May 2007 WO
2006098950 Nov 2007 WO
2007134608 Nov 2007 WO
2007128156 Feb 2008 WO
2008026106 Mar 2008 WO
2008078117 Jul 2008 WO
2008104019 Sep 2008 WO
2008141471 Nov 2008 WO
2009004368 Jan 2009 WO
2009004369 Jan 2009 WO
2009052496 Apr 2009 WO
2009007702 Jul 2009 WO
2009101738 Aug 2009 WO
2010058192 May 2010 WO
2010030122 Jul 2010 WO
2010101915 Jan 2011 WO
2011018132 Feb 2011 WO
2011018133 Feb 2011 WO
2011024864 Mar 2011 WO
2011054118 May 2011 WO
2011079132 Jun 2011 WO
2011107972 Sep 2011 WO
2011108972 Sep 2011 WO
2011117292 Sep 2011 WO
2011123219 Oct 2011 WO
2011132043 Oct 2011 WO
2012012908 Feb 2012 WO
2012065274 May 2012 WO
2012097462 Jul 2012 WO
2012098796 Jul 2012 WO
2012101288 Aug 2012 WO
2012175916 Dec 2012 WO
2013018435 Feb 2013 WO
2013033429 Mar 2013 WO
2013055434 Apr 2013 WO
2013082397 Jun 2013 WO
2013103291 Jul 2013 WO
2013131109 Sep 2013 WO
2013167478 Nov 2013 WO
2013177716 Dec 2013 WO
2014041534 Mar 2014 WO
2014046420 Mar 2014 WO
2014118518 Aug 2014 WO
2014160852 Oct 2014 WO
2015023599 Feb 2015 WO
2015052348 Apr 2015 WO
2015068384 May 2015 WO
2015169403 Nov 2015 WO
2015170307 Nov 2015 WO
2015197462 Dec 2015 WO
2016051385 Apr 2016 WO
2016055989 Apr 2016 WO
2016071894 May 2016 WO
2016103242 Jun 2016 WO
2016116915 Jul 2016 WO
2016124203 Aug 2016 WO
2016139448 Sep 2016 WO
2016166562 Oct 2016 WO
2016167535 Oct 2016 WO
2016191574 Dec 2016 WO
2016200088 Dec 2016 WO
2016200361 Dec 2016 WO
2016204731 Dec 2016 WO
2017001846 Jan 2017 WO
2017075226 May 2017 WO
2017152198 Sep 2017 WO
2017162559 Sep 2017 WO
2017205446 Nov 2017 WO
2017209779 Dec 2017 WO
2017210524 Dec 2017 WO
2018022414 Feb 2018 WO
2018044781 Mar 2018 WO
2018056953 Mar 2018 WO
2018090550 May 2018 WO
2018138513 Aug 2018 WO
2018144318 Aug 2018 WO
2018144463 Aug 2018 WO
2018150263 Aug 2018 WO
2018150268 Aug 2018 WO
2018152156 Aug 2018 WO
2018183791 Oct 2018 WO
2018150267 Nov 2018 WO
2018235026 Dec 2018 WO
2018235065 Dec 2018 WO
2019004404 Jan 2019 WO
2019065541 Apr 2019 WO
2019096845 May 2019 WO
2019150385 Aug 2019 WO
2019161094 Aug 2019 WO
2019188566 Oct 2019 WO
2019190593 Oct 2019 WO
2019212949 Nov 2019 WO
2019212950 Nov 2019 WO
2019212951 Nov 2019 WO
2019212952 Nov 2019 WO
2019212954 Nov 2019 WO
2019212955 Nov 2019 WO
2019212956 Nov 2019 WO
2019214787 Nov 2019 WO
2019214788 Nov 2019 WO
2020000994 Jan 2020 WO
2020020618 Jan 2020 WO
2020038822 Feb 2020 WO
2020088409 May 2020 WO
2020049394 Jun 2020 WO
2020120657 Jun 2020 WO
2020152575 Jul 2020 WO
2020182923 Sep 2020 WO
2020204967 Oct 2020 WO
2020209898 Oct 2020 WO
2020242790 Dec 2020 WO
2020251893 Dec 2020 WO
2020256865 Dec 2020 WO
2021007144 Jan 2021 WO
2021007345 Jan 2021 WO
2021010844 Jan 2021 WO
2021016026 Jan 2021 WO
2021016300 Jan 2021 WO
2021025919 Feb 2021 WO
2021034886 Feb 2021 WO
2021041123 Mar 2021 WO
2021094352 May 2021 WO
2021102296 May 2021 WO
2021138411 Jul 2021 WO
2021138414 Jul 2021 WO
2021155206 Aug 2021 WO
2021173436 Sep 2021 WO
2021195384 Sep 2021 WO
2021207621 Oct 2021 WO
2021211568 Oct 2021 WO
2021216419 Oct 2021 WO
2021247523 Dec 2021 WO
2021257202 Dec 2021 WO
2022006256 Jan 2022 WO
2022031943 Feb 2022 WO
2022035745 Feb 2022 WO
2022076427 Apr 2022 WO
2022086898 Apr 2022 WO
2022098536 May 2022 WO
2022125685 Jun 2022 WO
2022140545 Jun 2022 WO
2022150360 Jul 2022 WO
2022150463 Jul 2022 WO
2022159392 Jul 2022 WO
2022170182 Aug 2022 WO
2022182385 Sep 2022 WO
2022192188 Sep 2022 WO
2022192347 Sep 2022 WO
2023038945 Mar 2023 WO
2023038950 Mar 2023 WO
Non-Patent Literature Citations (566)
Entry
US 9,908,683 B2, 03/2018, Sandhausen et al. (withdrawn)
Advisory Action for U.S. Appl. No. 16/904,868 dated Jun. 15, 2022.
Final Office Action for U.S. Appl. No. 16/452,258 dated Jun. 14, 2022.
Final Office Action for U.S. Appl. No. 16/478,180 dated Jun. 22, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2021/051456 dated Jan. 19, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2021/055515 dated Jan. 28, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/011419 dated Jun. 7, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/012794 dated May 3, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/015471 dated May 16, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/016942 dated Jun. 8, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/018170 dated May 31, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/019254 dated Jun. 7, 2022.
Issue Notification for U.S. Appl. No. 17/088,272 dated Jun. 15, 2022.
Issue Notification for U.S. Appl. No. 17/330,657 dated Jun. 22, 2022.
Notice of Allowance for U.S. Appl. No. 29/741,751 dated Jun. 9, 2022.
U.S. Appl. No. 14/433,773, filed Apr. 3, 2020.
U.S. Appl. No. 17/664,914, filed May 25, 222.
U.S. Appl. No. 17/749,340, filed May 20, 2022.
U.S. Appl. No. 17/756,201, filed May 19, 2022.
U.S. Appl. No. 17/758,152, filed Jun. 29, 2022.
U.S. Appl. No. 17/758,316, filed Jul. 1, 2022.
U.S. Appl. No. 63/191,558, filed May 21, 2021.
Advisory Action for U.S. Appl. No. 14/722,613 dated Mar. 4, 2019.
Advisory Action for U.S. Appl. No. 14/952,591 dated Jun. 1, 2018.
Advisory Action for U.S. Appl. No. 15/238,427 dated Apr. 10, 2019.
Advisory Action for U.S. Appl. No. 16/899,956 dated Jul. 9, 2021.
Advisory Action for U.S. Appl. No. 16/904,868 dated Jul. 2, 2021.
Advisory Action for U.S. Appl. No. 16/905,400 dated Feb. 16, 2022.
Advisory Action for U.S. Appl. No. 16/905,400 dated Jun. 9, 2021.
Corrected International Search Report and Written Opinion for International Application No. PCT/US2017/043025 dated Jan. 11, 2018.
Corrected Notice of Allowability for U.S. Appl. No. 15/221,106 dated Jul. 2, 2019.
Corrected Notice of Allowability for U.S. Appl. No. 15/612,325 dated Mar. 17, 2021.
Corrected Notice of Allowability for U.S. Appl. No. 17/330,657 dated Dec. 9, 2021.
Final Office Action for U.S. Appl. No. 14/722,613 dated Nov. 29, 2018.
Final Office Action for U.S. Appl. No. 14/947,759 dated Apr. 8, 2016.
Final Office Action for U.S. Appl. No. 14/952,591 dated Feb. 23, 2018.
Final Office Action for U.S. Appl. No. 14/952,591 dated Nov. 1, 2019.
Final Office Action for U.S. Appl. No. 14/952,591 dated Nov. 27, 2020.
Final Office Action for U.S. Appl. No. 15/171,968 dated Feb. 14, 2020.
Final Office Action for U.S. Appl. No. 15/171,968 dated Mar. 19, 2019.
Final Office Action for U.S. Appl. No. 15/221,106 dated Jan. 23, 2019.
Final Office Action for U.S. Appl. No. 15/238,427 dated Jan. 2, 2019.
Final Office Action for U.S. Appl. No. 15/260,103 dated Feb. 14, 2019.
Final Office Action for U.S. Appl. No. 15/612,325 dated Sep. 17, 2020.
Final Office Action for U.S. Appl. No. 16/452,145 dated Mar. 25, 2022.
Final Office Action for U.S. Appl. No. 16/899,956 dated Apr. 19, 2021.
Final Office Action for U.S. Appl. No. 16/904,868 dated Mar. 10, 2022.
Final Office Action for U.S. Appl. No. 16/904,868 dated Mar. 26, 2021.
Final Office Action for U.S. Appl. No. 16/905,400 dated Apr. 6, 2021.
Final Office Action for U.S. Appl. No. 16/905,400 dated Dec. 9, 2021.
Final Office Action for U.S. Appl. No. 17/088,272 dated May 25, 2021.
Final Office Action for U.S. Appl. No. 29/624,661 dated Feb. 18, 2020.
International Search Report and Written Opinion from International Application No. PCT/US2016/049274 dated Dec. 1, 2016.
International Search Report and Written Opinion from International Application No. PCT/US2017/035625 dated Aug. 15, 2017.
International Search Report and Written Opinion from International Application No. PCT/US2017/043025 dated Oct. 18, 2017.
International Search Report and Written Opinion from International Application No. PCT/US2018/015968 dated Apr. 6, 2018.
International Search Report and Written Opinion from International Application No. PCT/US2019/029608 dated Sep. 3, 2019.
International Search Report and Written Opinion from International Application No. PCT/US2019/029609 dated Sep. 3, 2019.
International Search Report and Written Opinion from International Application No. PCT/US2019/029610 dated Sep. 3, 2019.
International Search Report and Written Opinion from International Application No. PCT/US2019/029611 dated Jul. 3, 2019.
International Search Report and Written Opinion from International Application No. PCT/US2019/029613 dated Jul. 3, 2019.
International Search Report and Written Opinion from International Application No. PCT/US2019/029614 dated Sep. 26, 2019.
International Search Report and Written Opinion from International Application No. PCT/US2019/029616 dated Aug. 30, 2019.
International Search Report and Written Opinion from International Application No. PCT/US2020/023572 dated Jul. 6, 2020.
International Search Report and Written Opinion from International Application No. PCT/US2020/033064 dated Aug. 31, 2020.
International Search Report and Written Opinion from International Application No. PCT/US2020/033122 dated Aug. 31, 2020.
International Search Report and Written Opinion from International Application No. PCT/US2020/040860 dated Oct. 2, 2020.
International Search Report and Written Opinion from International Application No. PCT/US2020/041242 dated Nov. 17, 2020.
International Search Report and Written Opinion from International Application No. PCT/US2020/041249 dated Oct. 2, 2020.
International Search Report and Written Opinion from International Application No. PCT/US2020/042262 dated Oct. 14, 2020.
International Search Report and Written Opinion from International Application No. PCT/US2020/043059 dated Oct. 6, 2020.
International Search Report and Written Opinion from International Application No. PCT/US2020/044024 dated Nov. 12, 2020.
International Search Report and Written Opinion from International Application No. PCT/US2020/046914 dated Dec. 1, 2020.
International Search Report and Written Opinion from International Application No. PCT/US2020/055680 dated Dec. 15, 2020.
International Search Report and Written Opinion from International Application No. PCT/US2020/057562 dated Jan. 27, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2020/061563 dated Feb. 19, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2020/065234 dated Apr. 12, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2020/067451 dated Mar. 25, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2020/067454 dated Mar. 29, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2020/067455 dated Mar. 26, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/015024 dated May 18, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/015787 dated May 27, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/023001 dated Jun. 21, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/024162 dated Jul. 8, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/026607 dated Jul. 29, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/027061 dated Jul. 19, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/027104 dated Jul. 6, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/027314 dated Jul. 6, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/027422 dated Aug. 12, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/027425 dated Aug. 11, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/027913 dated Jul. 12, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/027917 dated Aug. 19, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/035181 dated Sep. 16, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/043893 dated Nov. 22, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/044699 dated Nov. 22, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/045188 dated Jan. 26, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2021/047536 dated Dec. 23, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/048211 dated Dec. 22, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/048661 dated Feb. 14, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2021/049404 dated Jan. 18, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2021/053593 dated Apr. 11, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2021/056566 dated Feb. 11, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2021/060993 dated Mar. 18, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2021/062440 dated Mar. 28, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/011108 dated Apr. 22, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/011281 dated Apr. 25, 2022.
Issue Notification for U.S. Appl. No. 14/952,591 dated Jul. 28, 2021.
Issue Notification for U.S. Appl. No. 15/171,968 dated Mar. 3, 2021.
Issue Notification for U.S. Appl. No. 15/221,106 dated Jul. 24, 2019.
Issue Notification for U.S. Appl. No. 15/238,427 dated Jul. 24, 2019.
Issue Notification for U.S. Appl. No. 15/260,103 dated Aug. 7, 2019.
Issue Notification for U.S. Appl. No. 15/611,587 dated Feb. 20, 2019.
Issue Notification for U.S. Appl. No. 15/612,325 dated Mar. 24, 2021.
Issue Notification for U.S. Appl. No. 29/624,661 dated Aug. 4, 2021.
Non-Final Office Action for U.S. Appl. No. 14/592,591 dated Mar. 20, 2020.
Non-Final Office Action for U.S. Appl. No. 14/722,613 dated Jun. 13, 2019.
Non-Final Office Action for U.S. Appl. No. 14/947,759 dated Mar. 17, 2016.
Non-Final Office Action for U.S. Appl. No. 14/952,591 dated Aug. 1, 2017.
Non-Final Office Action for U.S. Appl. No. 14/952,591 dated Mar. 20, 2020.
Non-Final Office Action for U.S. Appl. No. 14/952,591 dated Mar. 21, 2019.
Non-Final Office Action for U.S. Appl. No. 14/952,591 dated Sep. 28, 2018.
Non-Final Office Action for U.S. Appl. No. 15/171,968 dated May 11, 2020.
Non-Final Office Action for U.S. Appl. No. 15/171,968 dated Aug. 20, 2019.
Non-Final Office Action for U.S. Appl. No. 15/171,968 dated Jun. 12, 2018.
Non-Final Office Action for U.S. Appl. No. 15/221,106 dated Jun. 5, 2018.
Non-Final Office Action for U.S. Appl. No. 15/238,427 dated Aug. 8, 2018.
Non-Final Office Action for U.S. Appl. No. 15/260,103 dated Sep. 26, 2018.
Non-Final Office Action for U.S. Appl. No. 15/611,587 dated Dec. 29, 2017.
Non-Final Office Action for U.S. Appl. No. 15/611,587 dated Jul. 13, 2018.
Non-Final Office Action for U.S. Appl. No. 15/612,325 dated Mar. 19, 2020.
Non-Final Office Action for U.S. Appl. No. 16/245,726 dated Jan. 21, 2022.
Non-Final Office Action for U.S. Appl. No. 16/369,676 dated Mar. 31, 2022.
Non-Final Office Action for U.S. Appl. No. 16/433,773 dated Apr. 21, 2022.
Non-Final Office Action for U.S. Appl. No. 16/449,039 dated Dec. 8, 2021.
Non-Final Office Action for U.S. Appl. No. 16/452,145 dated Sep. 28, 2021.
Non-Final Office Action for U.S. Appl. No. 16/452,258 dated Sep. 28, 2021.
Non-Final Office Action for U.S. Appl. No. 16/478,180 dated Oct. 22, 2021.
Non-Final Office Action for U.S. Appl. No. 16/899,956 dated Oct. 16, 2020.
Non-Final Office Action for U.S. Appl. No. 16/899,956 dated Sep. 2, 2021.
Non-Final Office Action for U.S. Appl. No. 16/904,868 dated Nov. 25, 2020.
Non-Final Office Action for U.S. Appl. No. 16/904,868 dated Oct. 5, 2021.
Non-Final Office Action for U.S. Appl. No. 16/905,400 dated Apr. 27, 2022.
Non-Final Office Action for U.S. Appl. No. 16/905,400 dated Dec. 2, 2020.
Non-Final Office Action for U.S. Appl. No. 16/905,400 dated Jul. 22, 2021.
Non-Final Office Action for U.S. Appl. No. 17/088,272 dated Jan. 25, 2021.
Non-Final Office Action for U.S. Appl. No. 17/330,657 dated Aug. 11, 2021.
Non-Final Office Action for U.S. Appl. No. 29/624,661 dated Jul. 18, 2019.
Non-Final Office Action for U.S. Appl. No. 29/694,002 dated Jun. 24, 2020.
Non-Final Office Action for U.S. Appl. No. 29/741,751 dated Jan. 18, 2022.
Notice of Allowance for U.S. Appl. No. 14/952,591 dated Apr. 5, 2021.
Notice of Allowance for U.S. Appl. No. 14/952,591 dated Jul. 8, 2021.
Notice of Allowance for U.S. Appl. No. 15/171,968 dated Feb. 16, 2021.
Notice of Allowance for U.S. Appl. No. 15/171,968 dated Nov. 6, 2020.
Notice of Allowance for U.S. Appl. No. 15/221,106 dated May 1, 2019.
Notice of Allowance for U.S. Appl. No. 15/238,427 dated May 23, 2019.
Notice of Allowance for U.S. Appl. No. 15/260,103 dated Jun. 7, 2019.
Notice of Allowance for U.S. Appl. No. 15/611,587 dated Dec. 21, 2018.
Notice of Allowance for U.S. Appl. No. 15/612,325 dated Feb. 19, 2021.
Notice of Allowance for U.S. Appl. No. 15/612,325 dated Jan. 21, 2021.
Notice of Allowance for U.S. Appl. No. 16/899,956 dated Apr. 19, 2022.
Notice of Allowance for U.S. Appl. No. 16/899,956 dated Dec. 29, 2021.
Notice of Allowance for U.S. Appl. No. 17/088,272 dated Aug. 5, 2021.
Notice of Allowance for U.S. Appl. No. 17/088,272 dated Mar. 4, 2022.
Notice of Allowance for U.S. Appl. No. 17/088,272 dated Nov. 24, 2021.
Notice of Allowance for U.S. Appl. No. 17/330,657 dated Mar. 16, 2022.
Notice of Allowance for U.S. Appl. No. 17/330,657 dated Nov. 26, 2021.
Notice of Allowance for U.S. Appl. No. 29/624,661 dated Apr. 28, 2021.
Notice of Allowance for U.S. Appl. No. 29/624,661 dated Jul. 10, 2020.
Notice of Allowance for U.S. Appl. No. 29/624,661 dated May 14, 2020.
Notice of Allowance for U.S. Appl. No. 29/624,661 dated Sep. 29, 2020.
Notice of Allowance for U.S. Appl. No. 29/694,002 dated Apr. 29, 2021.
Notice of Allowance for U.S. Appl. No. 29/694,002 dated Jan. 29, 2021.
Notice of Allowance for U.S. Appl. No. 29/694,002 dated Oct. 16, 2020.
Notice to File Missing Parts for U.S. Appl. No. 17/179,116 dated Mar. 3, 2021.
Restriction Requirement for U.S. Appl. No. 16/433,773 dated Dec. 7, 2021.
Restriction Requirement for U.S. Appl. No. 16/478,180 dated May 25, 2021.
U.S. Appl. No. 14/625,469, filed Feb. 28, 2015.
U.S. Appl. No. 14/947,759, filed Nov. 20, 2015.
U.S. Appl. No. 14/952,591, filed Nov. 25, 2015.
U.S. Appl. No. 15/171,968, filed Jun. 2, 2016.
U.S. Appl. No. 15/221,106, filed Jul. 27, 2016.
U.S. Appl. No. 15/260,103, filed Sep. 8, 2016.
U.S. Appl. No. 15/384,196, filed Dec. 19, 2016.
U.S. Appl. No. 15/611,587, filed Jun. 1, 2017.
U.S. Appl. No. 15/612,325, filed Jun. 2, 2017.
U.S. Appl. No. 16/245,726, filed Jan. 11, 2019.
U.S. Appl. No. 16/369,676, filed Mar. 29, 2019.
U.S. Appl. No. 16/433,773, filed Jun. 6, 2019.
U.S. Appl. No. 16/449,039, filed Jun. 21, 2019.
U.S. Appl. No. 16/452,145, filed Jun. 25, 2019.
U.S. Appl. No. 16/452,258, filed Jun. 25, 2019.
U.S. Appl. No. 16/478,180, filed Jul. 16, 2019.
U.S. Appl. No. 16/904,868, filed Jun. 18, 2020.
U.S. Appl. No. 16/905,400, filed Jun. 18, 2020.
U.S. Appl. No. 17/051,550, filed Oct. 29, 2020.
U.S. Appl. No. 17/051,554, filed Oct. 29, 2020.
U.S. Appl. No. 17/051,585, filed Oct. 29, 2020.
U.S. Appl. No. 17/051,600, filed Oct. 29, 2020.
U.S. Appl. No. 17/088,272, filed Nov. 3, 2020.
U.S. Appl. No. 17/179,116, filed Feb. 18, 2021.
U.S. Appl. No. 17/330,657, filed May 26, 2021.
U.S. Appl. No. 17/378,015, filed Jul. 16, 2021.
U.S. Appl. No. 17/394,055, filed Aug. 4, 2021.
U.S. Appl. No. 17/412,864, filed Aug. 26, 2021.
U.S. Appl. No. 17/444,825, filed Aug. 10, 2021.
U.S. Appl. No. 17/446,256, filed Aug. 27, 2021.
U.S. Appl. No. 17/446,654, filed Sep. 1, 2021.
U.S. Appl. No. 17/447,123, filed Sep. 8, 2021.
U.S. Appl. No. 17/450,864, filed Oct. 14, 2021.
U.S. Appl. No. 17/451,345, filed Oct. 19, 2021.
U.S. Appl. No. 17/451,354, filed Oct. 19, 2021.
U.S. Appl. No. 17/453,260, filed Nov. 2, 2021.
U.S. Appl. No. 17/453,560, filed Nov. 4, 2021.
U.S. Appl. No. 17/461,036 mailed Aug. 30, 2021.
U.S. Appl. No. 17/494,578, filed Oct. 5, 2021.
U.S. Appl. No. 17/501,591, filed Oct. 14, 2021.
U.S. Appl. No. 17/595,747, filed Nov. 23, 2021.
U.S. Appl. No. 17/597,408, filed Jan. 5, 2022.
U.S. Appl. No. 17/597,673, filed Jan. 18, 2022.
U.S. Appl. No. 17/614,173, filed Nov. 24, 2021.
U.S. Appl. No. 17/631,619, filed Jan. 31, 2022.
U.S. Appl. No. 17/645,821, filed Dec. 23, 2021.
U.S. Appl. No. 17/646,771, filed Jan. 3, 2022.
U.S. Appl. No. 17/653,314, filed Mar. 3, 2022.
U.S. Appl. No. 17/653,920, filed Mar. 8, 2022.
U.S. Appl. No. 17/654,156, filed Mar. 9, 2022.
U.S. Appl. No. 17/655,464, filed Mar. 18, 2022.
U.S. Appl. No. 17/657,474, filed Mar. 31, 2022.
U.S. Appl. No. 17/661,090, filed Apr. 28, 2022.
U.S. Appl. No. 17/662,700, filed May 10, 2022.
U.S. Appl. No. 17/754,736, filed Apr. 11, 2022.
U.S. Appl. No. 29/741,751, filed Jul. 15, 2020.
U.S. Appl. No. 61/955,537, filed Mar. 19, 2014.
U.S. Appl. No. 62/082,279, filed Nov. 20, 2014.
U.S. Appl. No. 62/084,078, filed Nov. 25, 2014.
U.S. Appl. No. 62/414,963, filed Oct. 31, 2016.
U.S. Appl. No. 62/452,437, filed Jan. 31, 2017.
U.S. Appl. No. 62/485,578, filed Apr. 14, 2017.
U.S. Appl. No. 62/665,297, filed May 1, 2018.
U.S. Appl. No. 62/665,302, filed May 1, 2018.
U.S. Appl. No. 62/665,317, filed May 1, 2018.
U.S. Appl. No. 62/665,321, filed May 1, 2018.
U.S. Appl. No. 62/665,331, filed May 1, 2018.
U.S. Appl. No. 62/665,335, filed May 1, 2018.
U.S. Appl. No. 62/853,279, filed May 28, 2019.
U.S. Appl. No. 62/853,889, filed May 29, 2019.
U.S. Appl. No. 62/864,656, filed Jun. 21, 2019.
U.S. Appl. No. 62/873,045, filed Jul. 11, 2019.
U.S. Appl. No. 62/873,048, filed Jul. 11, 2019.
U.S. Appl. No. 62/876,500, filed Jul. 19, 2019.
U.S. Appl. No. 62/877,558, filed Jul. 23, 2019.
U.S. Appl. No. 62/883,172, filed Aug. 6, 2019.
U.S. Appl. No. 62/889,149, filed Aug. 20, 2019.
U.S. Appl. No. 62/923,279, filed Oct. 18, 2019.
U.S. Appl. No. 62/926,767, filed Oct. 28, 2019.
U.S. Appl. No. 62/935,337, filed Nov. 14, 2019.
U.S. Appl. No. 62/938,447, filed Nov. 21, 2019.
U.S. Appl. No. 62/949,187, filed Dec. 17, 2019.
U.S. Appl. No. 62/956,756, filed Jan. 3, 2020.
U.S. Appl. No. 62/956,767, filed Jan. 3, 2020.
U.S. Appl. No. 62/956,770, filed Jan. 3, 2020.
U.S. Appl. No. 62/967,977, filed Jan. 30, 2020.
U.S. Appl. No. 62/994,912, filed Mar. 26, 2020.
U.S. Appl. No. 63/008,112, filed Apr. 10, 2020.
U.S. Appl. No. 63/011,445, filed Apr. 17, 2020.
U.S. Appl. No. 63/011,487, filed Apr. 17, 2020.
U.S. Appl. No. 63/011,571, filed Apr. 17, 2020.
U.S. Appl. No. 63/011,657, filed Apr. 17, 2020.
U.S. Appl. No. 63/011,760, filed Apr. 17, 2020.
U.S. Appl. No. 63/012,347, filed Apr. 20, 2020.
U.S. Appl. No. 63/012,384, filed Apr. 20, 2020.
U.S. Appl. No. 63/030,685, filed May 27, 2020.
U.S. Appl. No. 63/033,310, filed Jun. 2, 2020.
U.S. Appl. No. 63/047,374, filed Jul. 2, 2020.
U.S. Appl. No. 63/061,241, filed Aug. 5, 2020.
U.S. Appl. No. 63/061,244, filed Aug. 5, 2020.
U.S. Appl. No. 63/061,834, filed Aug. 6, 2020.
U.S. Appl. No. 63/064,017, filed Aug. 11, 2020.
U.S. Appl. No. 63/064,126, filed Aug. 11, 2020.
U.S. Appl. No. 63/067,542, filed Aug. 19, 2020.
U.S. Appl. No. 63/071,438, filed Aug. 28, 2020.
U.S. Appl. No. 63/071,821, filed Aug. 28, 2020.
U.S. Appl. No. 63/073,545, filed Sep. 2, 2020.
U.S. Appl. No. 63/073,553, filed Sep. 2, 2020.
U.S. Appl. No. 63/074,051, filed Sep. 3, 2020.
U.S. Appl. No. 63/074,066, filed Sep. 3, 2020.
U.S. Appl. No. 63/076,032, filed Sep. 9, 2020.
U.S. Appl. No. 63/076,474, filed Sep. 10, 2020.
U.S. Appl. No. 63/076,477, filed Sep. 10, 2020.
U.S. Appl. No. 63/082,261, filed Sep. 23, 2020.
U.S. Appl. No. 63/088,506, filed Oct. 7, 2020.
U.S. Appl. No. 63/088,511, filed Oct. 7, 2020.
U.S. Appl. No. 63/088,539, filed Oct. 7, 2020.
U.S. Appl. No. 63/094,464, filed Oct. 21, 2020.
U.S. Appl. No. 63/094,498, filed Oct. 21, 2020.
U.S. Appl. No. 63/094,594, filed Oct. 21, 2020.
U.S. Appl. No. 63/094,608, filed Oct. 21, 2020.
U.S. Appl. No. 63/094,626, filed Oct. 21, 2020.
U.S. Appl. No. 63/094,646, filed Oct. 21, 2020.
U.S. Appl. No. 63/109,066, filed Nov. 3, 2020.
U.S. Appl. No. 63/109,084, filed Nov. 3, 2020.
U.S. Appl. No. 63/112,417, filed Nov. 11, 2020.
U.S. Appl. No. 63/119,161, filed Nov. 30, 2020.
U.S. Appl. No. 63/124,271, filed Dec. 11, 2020.
U.S. Appl. No. 63/133,892, filed Jan. 5, 2021.
U.S. Appl. No. 63/134,287, filed Jan. 6, 2021.
U.S. Appl. No. 63/134,450, filed Jan. 6, 2021.
U.S. Appl. No. 63/134,631, filed Jan. 7, 2021.
U.S. Appl. No. 63/134,632, filed Jan. 7, 2021.
U.S. Appl. No. 63/134,754, filed Jan. 7, 2021.
U.S. Appl. No. 63/138,878, filed Jan. 19, 2021.
U.S. Appl. No. 63/146,946, filed Feb. 8, 2021.
U.S. Appl. No. 63/147,013, filed Feb. 8, 2021.
U.S. Appl. No. 63/147,299, filed Feb. 9, 2021.
U.S. Appl. No. 63/148,723, filed Feb. 12, 2021.
U.S. Appl. No. 63/154,248, filed Feb. 26, 2021.
U.S. Appl. No. 63/155,395, filed Mar. 2, 2021.
U.S. Appl. No. 63/157,007, filed Mar. 5, 2021.
U.S. Appl. No. 63/157,014, filed Mar. 5, 2021.
U.S. Appl. No. 63/159,142, filed Mar. 10, 2021.
U.S. Appl. No. 63/159,186, filed Mar. 10, 2021.
U.S. Appl. No. 63/159,210, filed Mar. 10, 2021.
U.S. Appl. No. 63/159,280, filed Mar. 10, 2021.
U.S. Appl. No. 63/165,273, filed Mar. 24, 2021.
U.S. Appl. No. 63/165,384, filed Mar. 24, 2021.
U.S. Appl. No. 63/171,165, filed Apr. 6, 2021.
U.S. Appl. No. 63/172,975, filed Apr. 9, 2021.
U.S. Appl. No. 63/181,695, filed Apr. 29, 2021.
U.S. Appl. No. 63/192,274, filed May 24, 2021.
U.S. Appl. No. 63/192,289, filed May 24, 2021.
U.S. Appl. No. 63/193,235, filed May 26, 2021.
U.S. Appl. No. 63/193,406, filed May 26, 2021.
U.S. Appl. No. 63/193,891, filed May 27, 2021.
U.S. Appl. No. 63/208,262, filed Jun. 8, 2021.
U.S. Appl. No. 63/214,551, filed Jun. 24, 2021.
U.S. Appl. No. 63/214,570, filed Jun. 24, 2021.
U.S. Appl. No. 63/215,017, filed Jun. 25, 2021.
U.S. Appl. No. 63/228,244, filed Aug. 2, 2021.
U.S. Appl. No. 63/228,252, filed Aug. 2, 2021.
U.S. Appl. No. 63/228,258, filed Aug. 2, 2021.
U.S. Appl. No. 63/230,894, filed Aug. 9, 2021.
U.S. Appl. No. 63/230,897, filed Aug. 9, 2021.
U.S. Appl. No. 63/238,457, filed Aug. 30, 2021.
U.S. Appl. No. 63/238,477, filed Aug. 30, 2021.
U.S. Appl. No. 63/241,562, filed Sep. 8, 2021.
U.S. Appl. No. 63/241,564, filed Sep. 8, 2021.
U.S. Appl. No. 63/241,575, filed Sep. 8, 2021.
U.S. Appl. No. 63/246,972, filed Sep. 22, 2021.
U.S. Appl. No. 63/247,375, filed Sep. 23, 2021.
U.S. Appl. No. 63/247,478, filed Sep. 23, 2021.
U.S. Appl. No. 63/247,491, filed Sep. 23, 2021.
U.S. Appl. No. 63/299,208, filed Jan. 13, 2022.
Sage's Second Supplemental Invalidity Contentions Regarding U.S. Pat. Nos. 8,287,508, 10,226,375, 10,390,989, and U.S. Pat. No. 10,376,407, 292 pages.
Plaintiff's Identification of Claim Terms and Proposed Constructions, 3 pages.
Sage's Preliminary Identification of Claim Elements and Proposed Constructions for U.S. Pat. Nos. 8,287,508, 10,226,376, 10,390,989 and U.S. Pat. No. 10,376,407, 7 pages.
Corrected Certificate of Service, 2020, 2 pages.
Excerpts from the 508 (U.S. Pat. No. 8,278,508) Patent's Prosecution History, 2020, 99 pages.
Declaration of Diane K. Newman Curriculum Vitae, 2020, pp. 1-199.
Sage's Supplemental and Initial Invalidity Contentions Regarding U.S. Pat. Nos. 8,287,508; 10,226,375; 10,390,989 and Initial Invalidity Contentions Regarding U.S. Pat. No. 10,376,407, Aug. 21, 2020, 277 pages.
Decision Granting Institution of Inter Partes Review for U.S. Pat. No. 8,287,508, dated Feb. 17, 2021, 39 pages.
Memorandum Order, Feb. 2021, 14 pgs.
Boehringer CareDry System—Second Generation for Non-Invasive Urinary Management for Females, Mar. 2021, 3 pgs.
PureWick's Response to Interrogatory No. 9 in PureWick, LLC v. Sage Products, LLC, Mar. 23, 2020, 6 pages.
Sage's Initial Invalidity Contentions Regarding U.S. Pat. Nos. 8,287,508; 10,226,375; and U.S. Pat. No. 10,390,989, May 29, 2020, 193 pages.
Defendant and Counterclaim Plaintiff Sage Products, LLC'S Answer, Defenses, and Counterclaims to Plaintiff's Amended Complaint, Nov. 1, 2019.
Plaintiff's Opening Claim Construction Brief, Oct. 16, 2020, 26 pages.
“3 Devices Take Top Honors in Dare-To-Dream Medtech Design Contest”, R+D Digest, Nov. 2013, 1 page.
“Advanced Mission Extender Device (AMDX) Products”, Omni Medical Systems, Inc., 15 pages.
“AMXD Control Starter Kit Brochure”, https://www.omnimedicalsys.com/index.php?page=products, 8 pages.
“AMXDmax In-Flight Bladder Relief”, Omni Medical; Omni Medical Systems, Inc., 2015.
“AMXDX—Advanced Mission Extender Device Brochure”, Omni Medical, 2 pages.
“External Urine Management for Female Anatomy”, https://www.strykercom/us/en/sage/products/sage-primafit.html, Jul. 2020, 4 pages.
“High Absorbancy Cellulose Acetate Electrospun Nanofibers for Feminine Hygiene Application”, https://www.sciencedirect.com/science/article/abs/pii/S2352940716300701?via%3Dihub, Jul. 2016, 3 pages.
“How Period Panties Work”, www.shethinx.com/pages/thinx-itworks, 2020, 10 pages.
“Hydrogel properties of electrospun polyvinylpyrrolidone and polyvinylpyrrolidone/poly(acrylic acid) blend nanofibers”, https://pubs.rsc.org/en/content/articlelanding/2015/ra/c5ra07514a#!divAbstract, 2015, 5 pages.
“In Flight Bladder Relief”, Omni Medical, 14 pages.
“Making Women's Sanitary Products Safer and Cheaper”, https://www.elsevier.com/connect/making-womens-sanitary-products-safer-and-cheaper, Sep. 2016, 10 pages.
“Novel Nanofibers Make Safe and Effective Absorbent for Sanitary Products”, https://www.materialstoday.com/nanomaterials/news/nanofibers-make-safe-and-effective-absorbent/, Oct. 2016, 3 pages.
“Research and Development Work Relating to Assistive Technology Jun. 2005”, British Department of Health, Nov. 2006, 40 pages.
“Rising Warrior Insulated Gallon Jug Cover”, https://www.amazon.com/Rising-Warrior-Insulated-Sleeve, 2021, 2 pages.
“Step by Step How Ur24 WorksHome”, http://medicalpatentur24.com, Aug 30, 2017, 4 pages.
“Underwear that absorbs your period”, Thinx!, 7 pages.
“Urine Bag Cover-Catheter Bag Cover 2000 ml Volume-Medline Style-Multiple Sclerosis-Spine Injury-Suprapublic Catheter-Bladder Incontinence”, https://www.etsy.com/listing/1142934658/urine-bag-cover-caatheter-bag-cover-2000, 2022, 1 page.
“User & Maintenance Guide”, Omni Medical, 2007, 16 pages.
“Vinyl Dust Cover, Janome #741811000, Janome, Sewing Parts Online”, https://www.sewingpartsonline.com/vinyl-dust-cover-janome-74181000, 2020, 2 pages.
“Winners Announced for Dare-to-Dream Medtech Design Challenge”, https://www.mddionline.com/design-engineering/winners-announced-dare-dream-medtech-design-challenge, 2014, 4 pages.
Ali , “Sustainability Assessment: Seventh Generation Diapers versus gDiapers”, The University of Vermont, Dec. 6, 2011, pp. 1-31.
Autumn , et al., “Frictional adhesion: a new angle on gecko attachment”, The Journal of Experimental Biology, 2006, pp. 3569-3579.
Cañas , et al., “Effect of nano- and micro-roughness on adhesion of bioinspired micropatterned surfaces”, Acta Biomaterialia 8, 2012, pp. 282-288.
Chaudhary , et al., “Bioinspired dry adhesive: Poly(dimethylsiloxane) grafted with poly(2-ethylhexyl acrylate) brushes”, European Polymer Journal, 2015, pp. 432-440.
Dai , et al., “Non-sticky and Non-slippery Biomimetic Patterned Surfaces”, Journal of Bionic Engineering, Mar. 2020, pp. 326-334.
Espinoza-Ramirez , “Nanobiodiversity and Biomimetic Adhesives Development: From Nature to Production and Application”, Journal of Biomaterials and Nanobiotechnology, pp. 78-101, 2019.
Hollister , “Female Urinary and Pouch and Male Urinary Pouch Brochure”, 2011, 1 page.
Hollister , “Male Urinary Pouch External Collection Device”, http://www.hollister.com/en/products/Continence-Care-Products/Urine-Collectors/Urine-Collection-Accessories/Male-Urinary-Pouch-External-Collection-Device.
Hollister , “Retracted Penis Pouch by Hollister”, Vitality Medical.com, 6 pages.
Hwang , et al., “Multifunctional Smart Skin Adhesive Patches for Advanced Health Care”, Adv. Healthcare Mater, 2018, pp. 1-20.
Jagota , et al., “Adhesion, friction, and compliance of bio-mimetic and bio-inspired structured interfaces”, Materials Science and Engineering, 2011, pp. 253-292.
Jeong , et al., “A nontransferring dry adhesive with hierarchical polymer nanohairs”, PNAS, Apr. 7, 2009, pp. 5639-5644.
Jeong , et al., “Nanohairs and nanotubes: Efficient structural elements for gecko-inspired artificial dry adhesives”, Science Direct, 2009, pp. 335-346.
Karp , et al., “Dry solution to a sticky problem”, Nature., 2011, pp. 42-43.
Lee , et al., “Continuous Fabrication of Wide-Tip Microstructures for Bio-Inspired Dry Adhesives via Tip Inking Process”, Journal of Chemistry, Jan. 2, 2019, pp. 1-5.
Macaulay , et al., “A Noninvasive Continence Management System: Development and Evaluation of a Novel Toileting Device for Women”, The Wound, Ostomy and Continence Nurses Society, 2007, pp. 641-648.
Newman , et al., “The Urinary Incontinence Sourcebook”, Petition for Interparties Review, 1997, 23 pages.
Newton , et al., “Measuring Safety, Effectiveness and Ease of Use of PureWick in the Management of Urinary Incontinence in Bedbound Women: Case Studies”, Jan. 8, 2016, 11 pages.
Parmar , “10 Finalists Chosen for Dare-to-Dream Medtech Design Challenge (PureWick)”, Design Services, Nov. 10, 2014, 3 pages.
Parness , et al., “A microfabricated wedge-shaped adhesive array displaying gecko-like dynamic adhesion, directionality”, J.R. Soc. Interface, 2009, pp. 1223-1232.
Purewick , “Incontinence Relief for Women”, Presentation, Sep. 23, 2015, 7 pages.
Pytlik , “Super Absorbent Polymers”, University of Buffalo.
Sachtman , “New Relief for Pilots? It Depends”, Wired, 2008, 2 pages.
Tsipenyuk , et al., “Use of biomimetic hexagonal surface texture in friction against lubricated skin”, Journal of the Royal Society—Interface, 2014, pp. 1-6.
Advisory Action for U.S. Appl. No. 16/452,258 dated Oct. 26, 2022.
Advisory Action for U.S. Appl. No. 16/478,180 dated Sep. 21, 2022.
Final Office Action for U.S. Appl. No. 16/245,726 dated Nov. 25, 2022.
Final Office Action for U.S. Appl. No. 16/369,676 dated Dec. 5, 2022.
Final Office Action for U.S. Appl. No. 16/433,773 dated Oct. 25, 2022.
Final Office Action for U.S. Appl. No. 16/449,039 dated Aug. 1, 2022.
Final Office Action for U.S. Appl. No. 17/662,700 dated Sep. 30, 2022.
International Search Report and Written Opinion from International Application No. PCT/IB2021/057173 dated Nov. 5, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2021/039866 dated Oct. 7, 2021.
International Search Report and Written Opinion from International Application No. PCT/US2022/011421 dated Jun. 13, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/014285 dated Sep. 28, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/014749 dated Sep. 28, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/015026 dated Oct. 31, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/015045 dated Sep. 9, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/015073 dated Sep. 8, 2022.
International Search Report and Written Opinion from international Application No. PCT/US2022/015418 dated Nov. 11, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/015420 dated Nov. 18, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/015492 dated Apr. 26, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/015781 dated May 6, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/018159 dated Dec. 12, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/019480 dated Jun. 13, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/021103 dated Jun. 23, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/022111 dated Oct. 26, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/023594 dated Jul. 12, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/026667 dated Aug. 22, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/030685 dated Oct. 31, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/031032 dated Sep. 9, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/032424 dated Oct. 11, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/034457 dated Oct. 12, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/034744 dated Dec. 9, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/039714 dated Nov. 22, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/042719 dated Dec. 5, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/044107 dated Dec. 23, 2022.
Issue Notification for U.S. Appl. No. 16/905,400 dated Nov. 30, 2022.
Non-Final Office Action for U.S. Appl. No. 16/478,180 dated Dec. 20, 2022.
Non-Final Office Action for U.S. Appl. No. 17/051,550 dated Dec. 15, 2022.
Non-Final Office Action for U.S. Appl. No. 17/451,345 dated Dec. 7, 2022.
Non-Final Office Action for U.S. Appl. No. 17/662,700 dated Jul. 22, 2022.
Notice of Allowance for U.S. Appl. No. 16/449,039 dated Dec. 15, 2022.
Notice of Allowance for U.S. Appl. No. 16/899,956 dated Aug. 10, 2022.
Notice of Allowance for U.S. Appl. No. 16/899,956 dated Dec. 1, 2022.
Notice of Allowance for U.S. Appl. No. 16/905,400 dated Aug. 17, 2022.
Notice of Allowance for U.S. Appl. No. 17/461,036 dated Oct. 6, 2022.
U.S. Appl. No. 17/664,914, filed May 25, 2022.
U.S. Appl. No. 17/759,697, filed Jul. 28, 2022.
U.S. Appl. No. 17/878,268, filed Aug. 1, 2022.
U.S. Appl. No. 17/907,125, filed Sep. 23, 2022.
U.S. Appl. No. 17/912,147, filed Sep. 16, 2022.
U.S. Appl. No. 17/929,887, filed Sep. 6, 2022.
U.S. Appl. No. 17/930,238, filed Sep. 7, 2022.
U.S. Appl. No. 17/933,590, filed Sep. 20, 2022.
U.S. Appl. No. 17/996,064, filed Oct. 12, 2022.
U.S. Appl. No. 17/996,155, filed Oct. 13, 2022.
U.S. Appl. No. 17/996,253, filed Oct. 14, 2022.
U.S. Appl. No. 17/996,468, filed Oct. 18, 2022.
U.S. Appl. No. 17/996,556, filed Oct. 19, 2022.
U.S. Appl. No. 17/999,648, filed Nov. 22, 2022.
U.S. Appl. No. 18/003,029, filed Dec. 22, 2022.
U.S. Appl. No. 62/967,158, filed Jan. 26, 2020.
U.S. Appl. No. 62/991,754, filed Mar. 19, 2020.
U.S. Appl. No. 63/241,328, filed Sep. 7, 2021.
Advisory Action for U.S. Appl. No. 16/245,726 dated Apr. 19, 2023.
Advisory Action for U.S. Appl. No. 16/369,676 dated Mar. 24, 2023.
Advisory Action for U.S. Appl. No. 16/433,773 dated Feb. 15, 2023.
Advisory Action for U.S. Appl. No. 17/662,700 dated Jan. 30, 2023.
Final Office Action for U.S. Appl. No. 17/051,399 dated Mar. 9, 2023.
International Search Report and Written Opinion from International Application No. PCT/US2022/039018 dated Jan. 10, 2023.
International Search Report and Written Opinion from International Application No. PCT/US2022/039022 dated Jan. 10, 2023.
International Search Report and Written Opinion from International Application No. PCT/US2022/039711 dated Jan. 12, 2023.
International Search Report and Written Opinion from International Application No. PCT/US2022/041085 dated Mar. 16, 2023.
International Search Report and Written Opinion from International Application No. PCT/US2022/042725 dated Dec. 19, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/044212 dated Jan. 20, 2023.
International Search Report and Written Opinion from International Application No. PCT/US2022/044243 dated Feb. 24, 2023.
Issue Notification for U.S. Appl. No. 16/899,956 dated Mar. 29, 2023.
Non-Final Office Action for U.S. Appl. No. 16/433,773 dated Apr. 11, 2023.
Non-Final Office Action for U.S. Appl. No. 16/452,145 dated Mar. 28, 2023.
Non-Final Office Action for U.S. Appl. No. 16/452,258 dated Apr. 26, 2023.
Non-Final Office Action for U.S. Appl. No. 16/904,868 dated Mar. 15, 2023.
Non-Final Office Action for U.S. Appl. No. 17/051,585 dated Mar. 29, 2023.
Non-Final Office Action for U.S. Appl. No. 17/179,116 dated Mar. 24, 2023.
Non-Final Office Action for U.S. Appl. No. 17/444,792 dated Feb. 10, 2023.
Non-Final Office Action for U.S. Appl. No. 17/446,256 dated Apr. 13, 2023.
Non-Final Office Action for U.S. Appl. No. 17/448,811 dated Mar. 1, 2023.
Non-Final Office Action for U.S. Appl. No. 17/453,260 dated Mar. 14, 2023.
Non-Final Office Action for U.S. Appl. No. 17/653,137 dated Apr. 7, 2023.
Non-Final Office Action for U.S. Appl. No. 17/655,464 dated Mar. 14, 2023.
Notice of Allowance for U.S. Appl. No. 17/461,036 dated Feb. 22, 2023.
Notice of Allowance for U.S. Appl. No. 17/662,700 dated Mar. 28, 2023.
Restriction Requirement for U.S. Appl. No. 17/326,980 dated Mar. 20, 2023.
Restriction Requirement for U.S. Appl. No. 17/446,256 dated Jan. 23, 2023.
Restriction Requirement for U.S. Appl. No. 17/646,771 dated Apr. 6, 2023.
Text Messages to Lorena Eckert Re Prototype PureWick Holder dated Apr. 16, 2022.
U.S. Appl. No. 18/006,807, filed Jan. 25, 2023.
U.S. Appl. No. 18/007,105, filed Jan. 27, 2023.
U.S. Appl. No. 18/041,109, filed Feb. 9, 2023.
U.S. Appl. No. 18/042,842, filed Feb. 24, 2023.
U.S. Appl. No. 18/043,618, filed Mar. 1, 2023.
U.S. Appl. No. 18/115,444, filed Feb. 28, 2023.
U.S. Appl. No. 18/134,857, filed Apr. 14, 2023.
U.S. Appl. No. 18/164,800, filed Feb. 6, 2023.
U.S. Appl. No. 18/246,121, filed Mar. 21, 2023.
U.S. Appl. No. 18/247,986, filed Apr. 5, 2023.
U.S. Appl. No. 18/299,788, filed Apr. 13, 2023.
U.S. Appl. No. 63/308,190, filed Feb. 9, 2022.
Final Office Action for U.S. Appl. No. 16/478,180 dated May 31, 2023.
Final Office Action for U.S. Appl. No. 17/051,550 dated May 23, 2023.
Final Office Action for U.S. Appl. No. 17/051,585 dated Jul. 27, 2023.
Final Office Action for U.S. Appl. No. 17/444,792 dated Jun. 15, 2023.
Final Office Action for U.S. Appl. No. 17/448,811 dated Aug. 3, 2023.
Final Office Action for U.S. Appl. No. 17/451,345 dated May 3, 2023.
International Search Report and Written Opinion from International Application No. PCT/US2022/041688 dated Nov. 21, 2022.
International Search Report and Written Opinion from International Application No. PCT/US2022/043818 dated Mar. 24, 2023.
International Search Report and Written Opinion from International Application No. PCT/US2022/044208 dated May 8, 2023.
International Search Report and Written Opinion from International Application No. PCT/US2022/049300 dated Jun. 6, 2023.
Non-Final Office Action for U.S. Appl. No. 16/449,039 dated Apr. 27, 2023.
Non-Final Office Action for U.S. Appl. No. 17/326,980 dated Jul. 11, 2023.
Non-Final Office Action for U.S. Appl. No. 17/450,864 dated May 10, 2023.
Non-Final Office Action for U.S. Appl. No. 17/451,354 dated May 3, 2023.
Non-Final Office Action for U.S. Appl. No. 17/501,591 dated Apr. 25, 2023.
Non-Final Office Action for U.S. Appl. No. 17/646,771 dated Jul. 5, 2023.
Non-Final Office Action for U.S. Appl. No. 17/661,090 dated Jul. 6, 2023.
Non-Final Office Action for U.S. Appl. No. 17/663,330 dated Jun. 29, 2023.
Non-Final Office Action for U.S. Appl. No. 17/664,487 dated Jun. 8, 2023.
Notice of Allowance for U.S. Appl. No. 16/245,726 dated Jul. 6, 2023.
Notice of Allowance for U.S. Appl. No. 17/051,554 dated Jul. 6, 2023.
Notice of Allowance for U.S. Appl. No. 17/461,036 dated Jun. 30, 2023.
Notice of Allowance for U.S. Appl. No. 17/662,700 dated Jul. 28, 2023.
Notice of Allowance for U.S. Appl. No. 18/299,788 dated Jul. 24, 2023.
Restriction Requirement for U.S. Appl. No. 17/657,474 dated Jun. 30, 2023.
U.S. Appl. No. 17/664,487, filed May 23, 2022.
U.S. Appl. No. 18/140,163, filed Apr. 27, 2023.
U.S. Appl. No. 18/140,751, filed Apr. 28, 2023.
U.S. Appl. No. 18/198,464, filed May 17, 2023.
U.S. Appl. No. 18/259,626, filed Jun. 28, 2023.
U.S. Appl. No. 18/260,122, filed Jun. 30, 2023.
U.S. Appl. No. 18/260,391, filed Jul. 5, 2023.
U.S. Appl. No. 18/260,394, filed Jul. 5, 2023.
U.S. Appl. No. 18/263,800, filed Aug. 1, 2023.
U.S. Appl. No. 18/264,004, filed Aug. 2, 2023.
U.S. Appl. No. 18/265,736, filed Jun. 7, 2023.
U.S. Appl. No. 18/335,579, filed Jun. 15, 2023.
PureWick Corporation v. Sage Products, LLC Transcripts vol. 5, Apr. 1, 2022, 72 pages.
PureWick Corporation v. Sage Products, LLC Transcripts vol. 1, Mar. 28, 2022, 99 pages.
PureWick Corporation v. Sage Products, LLC Transcripts vol. 2, Mar. 29, 2022, 106 pages.
PureWick Corporation v. Sage Products, LLC Transcripts vol. 3, Mar. 30, 2022, 115 pages.
PureWick Corporation v. Sage Products, LLC Transcripts vol. 4, Mar. 31, 2022, 117 pages.
“AMXD Control Starter Kit”, Omni Medical Systems, Inc., 1 page.
“AMXDmax Advanced Mission Extender Device User & Maintenance Guide”, Omni Medical, Jan. 11, 2010, 10 pages.
“AMXDmax Development History 2002-2014”, Omni Medical Systems, Inc., 2 pages.
“Combat Force Multiplier in Flight Bladder Relief Cockpit Essential Equipment Brochure”, Omni Medical, 20 pages.
“GSA Price List”, Omni Medical, Apr. 2011, 2 pages.
“How is Polypropylene Fiber Made”, https:www.yarnsandfibers.com/textile-resources/synthetic-fibers/polypropylene-fiber/polypropylene-fiber-production-raw-materials/how-is-polypropylene-fiber-made/ last accessed 2020, Oct. 7, 2020, 3 pages.
“Letter to Mark Harvie of Omni Measurement Systems”, Department of Veterans Affairs, Nov. 1, 2007, 11 pages.
“Revised AMXDmax Advanced Mission Extender Device User & Maintenance Guide”, Omni Medical Systems, Oct. 8, 2019, 52 pages.
Pieper, et al., “An external urine-collection device for women: A clinical trial”, Journal of ER Nursing, vol. 20, No. 2, Mar./Apr. 1993, pp. 51-55.
Vinas, “A Solution For An Awkward—But Serious—Subject”, http://www.aero-news.net/index.cfm?do=main.textpost&id=69ae2bb1-838b-4098-a7b5-7flbb2505688 last accessed Feb. 8, 2021, 3 pages.
Related Publications (1)
Number Date Country
20220339023 A1 Oct 2022 US
Provisional Applications (1)
Number Date Country
63138878 Jan 2021 US
Continuations (1)
Number Date Country
Parent PCT/US2022/012794 Jan 2022 US
Child 17663046 US